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Abstract
Muthukuri, Karththikka Ramani, M.S. The University of Memphis. December
2013. Query-based Sampling and Multi-layered Semantic Analysis to find Robust
Network of Association between Drugs and Diseases. Major Professor: Dr. Mohammed
Yeasin.
This thesis presents the design and implementation of a system to discover
semantically related networks of diseases-drugs associations, called DDNet, from
medical literature. A fully functional DDNet can be transformative in identification of
“drug targets” and may open new avenues for “drug repositioning” in clinical and
translational research. In particular, a local latent semantic analysis (LLSA) was
introduced to implement a system that is efficient, scalable and relatively free from
systemic bias. In addition, a query-based sampling was introduced to find representative
samples from the “ocean of data” to build model that is relatively free from “garbage-in
garbage-out” syndrome. Also the concept of mapping ontologies was adopted to
determine relevant results and reverse ontology mapping were used to create a network of
associations. In addition, a Web service application was developed to query the system
and visualize the computed network of associations in a form that is easy to interact. A
pilot study was conducted to evaluate the performance of system using both subjective
and objective measures. The PharmGKB was used as a gold standard and the PR curve
was obtained from a large number of queries at different recall points. Empirical analyses
suggest that DDNet is robust, relatively stable and scalable over traditional Global LSA
model.
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CHAPTER 1

Introduction

The modern advancement in high throughput technology and growth in research
capacity resulted in producing large scale biological data. Unlike other research output,
which may be preserved as equations or values, biological data are usually preserved in
publications discussing them. That led to exponential growth of biomedical literature.
This wealth of scholarly knowledge is of significant importance for researchers in making
scientific discoveries and healthcare professionals in managing health-related matters.
However, the acquisition of such information is becoming increasingly difficult due to its
large volume and rapid growth.But, due to massive volume, there is a huge gap between
the generated knowledge in the published literature and consumption of that knowledge.
PubMed [1] is a free online resource which contains all Medline citations in the field of
science. It serves as the primary tool for electronically searching and retrieving
biomedical literature and, has currently approximately over 22 million abstracts [2]. This
wealth of literature knowledge is of significant importance for researchers in making
scientific discoveries and, healthcare professionals in managing health-related matters.
Also, PubMed is up to date and it is queried by millions of users around the globe every
day. As a negative side, PubMed frequently results in hundreds, thousands or even
millions of publications for a single query, as an unranked list as shown in the Figure 1.
These many retrievals for a single query is huge enough even for the expertise in the field
to read through and seek the necessary information for what he/she is looking. Hence,
knowledge gap still exists between the published literature and useful acquisition of it.
1

Figure 1 Screen shot showing the number of publications in PubMed.

Lot of web tools has been developed as PubMed search tools, complementary to
PubMed. These web tools filtered down the PubMed retrieved publications based on their
modeling. iPubMed [3] is one such PubMed search tool which narrows down PubMed
results on the basis of user’s relevance feedback. For instance, PubMed retrieved 67314
publications for query “Alzheimer Disease”, shown in Figure 2 and iPubMed retrieved
few hundred publications for the same query, shown in Figure 3.

2

Figure 2 Screen shot showing the retrieved publications from PubMed for the query
“Alzheimer disease”.

3

Figure 3 Screen shot showing the retrieved publications from iPubMed and from a
network. iPubMed retrieves 20 pages of publications for the query “Alzheimer disease”,
which is infeasble for the users to gather information. A network showing the crisp
associations of biological concepts for the same query “Alzheimer disease”.

Though PubMed search tools narrowed down the results, still few hundreds will
not bridge the knowledge gap. Also, the above mentioned web tools result flat list of
unranked publications, relying on keyword based search. There is high probability that
human readers may miss the significant information or may miss to gather important
biological concept associations. Hence, if a web tool can retrieve network of biological
concept associations, users will be benefited by obtaining precise information, as network
gathers fragments of information. Hence network would be comparatively an efficient
tool to bridge the knowledge gap. The inter-relationships between biological entities
drive to create web tools capable of capturing the semantic association between them.
4

AliBaba [4] and PubMed-EX are geared towards semantic enrichment by identifying
biomedical entities from the text. In addition, AliBaba also presents co-occurrence results
in a graph. Hence, network of semantically related association of biological concepts can
retrieve undiscovered associations, thereby aiding the researchers to generate new
hypothesis.
With the nagatives of PubMed and PubMed search tools taken into account and
advantages of network of semantic associations of biological concepts, this study is
motivated. Developing an Drug-Disease ineraction framework DDNet to aid the process
of Drug Repositioning by finding their candidates. Pharmaceutical research and
development productivity has significantly declined in recent decade [2] based on the
number of drugs approved and the amount of dollars spent for such an approval. To
resolve this issue, Drug repositioning has been used as a strategy for decades to get drugs
to more patients [5] and exploiting drug–disease relationships would be an efficient way
for computational drug repositioning [6]. So, automated discovery of semantically related
network of drug- diseases from medical literature can be transformative in clinical and
translational research as well as improving health-care delivery by aiding drug
repositioning. However the developed networks are mostly based on genomic expression
profiles and protein connectivity maps [7, 8]. These networks could also be generated
from literature data to cover most of the drug targets as well as to uncover the unknown
potential associations.
To construct a drug-disease network from literature data, an efficient and less
computational complexity informational retrieval technique is imperative. Latent
Semantic Analysis (LSA) [9] is such a widely used semantic information retrieval
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technique in the field of Bioinformatics. It identifies and retrieves direct as well as
indirect associations by finding higher order co-occurrence of terms in the data. LSA has
been shown to be extremely useful in information retrieval but drops its performance
when applying to the whole document collection [10]. LSA transforms the original
textual data into semantic space by capturing the implicit higher order structure in the
association of words through SVD decomposition. When SVD is performed on the term
document matrix from the whole data, it pays no attention to the class discrimination and
places the documents from different categories near to each other in reduced semantic
space. This results in poor performance of the system.
This thesis designs and implements an efficient, scalable, robust and relatively
bias free drug-disease interaction framework DDNet. This web tool enhances the
literature search by finding semantically related entities through the integration of local
LSA and Query Based Sampling. Several parameters have to be taken care of to construct
an adaptive, robust, efficient, bias free and scalable web tool of network of semantic
Drug-Disease associations. First, data extraction that makes the web tool to be used for
targeted audience. Second, domain specific dictionary that defines the global dynamic
feature range for the model. Third, semantic analysis model to identify the relavant
concepts for queries. Fourth, data driven thresholds to classify the retrieved results at
different levels of associations. Finally, an user friendly interface to visualize the results
based on the intensity of information need. All five mentioned parameters are critical to
the success of web tools to meet the expectation of consumers with different needs and
desires. Constructing an interaction network in the specific domain requires a dataset that
is wide in its scope and can provide precise biological knowledge. Literature data is the
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only source of knowledge with wide extent of information from different sources in the
domain of biology. Hence, titles and abstracts of PubMed have been extracted for the
selected biological concepts and utilized by the studies to extract the necessary
associations. MeSH, controlled vocabulary thesaurus, maintained by NCBI, is used or
dictionary creation by possible combination of terms.
Over the past few years, CVPIA Lab has been focused to bridge the knowledge
gap by developing network of associations, based on concepts. Domain specific multi
gram dictionary terms are created by ontology mapping of MeSH terms in ARIANA [11].
The results showed that quality of results are greatly enhanced by this dictionary. Also,
multi gram dictionary, partly alleviates one of the drawbacks of semantic analysis, LSA,
losing the biological meaning. Scalable network of drug-disease, requires a domain
specific dictionary, out of which more drugs/chemicals can be incorporated into the
underlying model. Drugs for this proposed study are derived from MeSH, as PubMed
abstracts are annotated with MeSH keywords for easy search and retrieval. Hence,
dictionary creation by ARIANA has been adopted for DDNet framework.
A web based tool, PharmNet is developed in CVPIA lab to explore the
relationships between pharmaceutical factors such as cellular components, chemical
compounds, biological factors, diseases, diagnosis, procedures etc. In this study,
constructive research has been done to address one of the drawbacks of LSA. Biological
entities for the model are selected from MeSH based on statistical analysis, to alleviate
systemic bias problem of LSA. MeSH terms have a heirarichal tree structure with
different levels. PharmNet conducted statistical studies to select terms such that they are
not too general and not too specific. Too general terms have several publications and will
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be retrieved by LSA model, with low association values against the query. On the other
side, too specific terms have very few publications and will be retrieved with high
association values against the query. One of the vital task of this Drug-Disease network
study is to create a relatively bias free semantic model. Hence, selected drugs for
PharmNet have been used for defining the feature range of this study. Additonally, care
has been taken for the presence of selected drugs in PharmGKB [12], the gold standard,
used for validating the drug-disease interaction tool.
DDNet has four major modules: (1) Local LSA models to create scalable and
relatively bias free framework. As global or traditional LSA is applied to the entire
abstract collection from different classes or categories, it captures irrelevant second order
co-occurrence of terms from these varied classes; thereby, capturing misleading higher
order semantic patterns of associations in the data. As a result, the retrieved information
from the model may not be a precise or even the accurately extracted associations may
not be resulted with confidence. Local LSA (LLSA) models are developed and
implemented by localizing conceptual relevant entities (drugs in this study) into a
separate models, thereby ensuring higher mutual independence between models. The
computational complexity will not be high for LLSA models, as the matrices out of
which models are generated will be of low dimension. Hence scalability issue can also be
resolved by LLSA models. (2) Query Based Sampling (QBS) of abstacts was introduced
to define each of the local spaces and thereby the models with representative samples of
information. QBS can ensure the models to be free from garbage-in, garbage-out
syndrome. (3) Pre-computed results for enhancing the effieiciency (4) Finally, an easyto-use interface with proper visualization is developed, which is critical to the success of
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a web tool. It would be able to retrieve the ranked results for any user query, based on the
user’s intensity of information need. In this way, the tool would meet the needs of
consumers with diverse needs and desires. Relevance model was implemented, to provide
range of services to users in biomedicine. It translates the ranked list of results into three
categories of connections such as highly related, related and not related. A relevance
model was also incorporated into this study, to make the Web tool, created from this
study, to provide flexibility needed to serve a diverse range of users. DDNet provides the
user the options of choosing highly relevant, reasonably relevant and poorly relevant
results based on the intensity of information needs.
Goals and Objectives
Literature data contains redundant information which would degrade the
robustness of the information retrieval; also the traditional LSA suffers from its own
limitations of scalability and systemic bias. Query Based Sampling is to incorporate
relevant information into the model and Local LSA (LLSA) models to address the
limitations of traditional LSA model. The goal of this thesis is to develop a scalable,
efficient, robust, unbiased, complete and generalized literature mining framework in the
Pharmaceutical domain with the underlying proposed LLSA model to model network of
semantically related drug-disease associations.


Optimize the selection of drug entities to define the feature range for
developing the model



Localize the drug entities to each one of the model’s region



Develop the multi gram model to preserve the biological meaning of the
terms by creating multi gram dictionary
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Define the regions of local LSA models by sampling and loading it with
more relevant representative samples of textual data



Generate the bias free Global LSA model by combining local models
generated



Develop an interface with the underlying model generated which
constructs the drug disease network based on user’s query



Pre-compute the associated factors for all the possible user
queries possible with the constraint of within the dictionary range



Validate the network against the chosen Gold Standard PharmGKB
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CHAPTER II

Background
Due to the voluminous biomedical literature there have been lot of effort in
developing literature mining techniques by the research community. Shatkey [13]
describes some of the literature mining techniques as an overview. Natural Language
Processing and machine learning techniques have been applied to unstructured biological
text and transform them into structured and computational form to analyze the functional
concepts of biological compounds. Also, domain specific search engines have also been
built to find the most relevant publications for the user's need.
More interest has been shown to find the associated biological concepts based on
semantics rather than keyword based search. FACTA [14] is one such text search engine
for MEDLINE abstracts, which retrieves the associated biological concepts based on
user's query. It provides the results in a tabular format in the ranked order, where the
ranking of the biological concepts are based on co-occurrence of statistics of terms with
the user's query. PubMatrix [15] is a simple web tool that mines PubMed using couple of
lists of terms and retrieves the co-occurrence terms. Chillibot [16] is content rich software
which mines PubMed database to retrieve the relationships between genes, proteins or for
any user's information need. The results are displayed graphically, as well as in the form
of sentences containing the terms on which the user is interested to look for relationships.
GeneIndexer [17] is a robust tool to retrieve and rank the genes based on user's
phenotype, cell etc. Parsing is done on full text articles with the hypothesis that biological
concepts occurring in the same sentence are somehow associated though biological
process. AliBaba [4] is an interactive tool for graphical summarization of search results
11

extracted on the fly from PubMed query. It parses the abstracts that fit for a PubMed
query and presents the extracted information for biological objects such as proteins,
diseases and drugs and their relationships as a graphical network. MiSearch [18] is an
adaptive literature search tool using implicit relevance feedback, helps users to rapidly
find PubMed citations relevant to their specific interests.
Effort has been laid in Pharmagenomic literature mining as well. PharmGKB [1921] is one such comprehensive resource for pharmacogenomics including impact of
genetic variations on drug response, biological pathways, relationships between drugs,
genes and diseases etc. It is thoroughly a knowledge base on pharmacogenes, their snps,
pharmacokinetics and pharmacodynamic pathways to achieve personalized medicine. It
contains data on genes ( > 20000), diseases ( > 3000) and drugs ( > 2500), SNPs (450).
Sentence level co-occurrence is used to mine and characterize the gene-drug relationships
from PubMed abstracts with a recall of 51% and precision of 60% [22]. Semantic
networks have been created with pharmacogenomics knowledge [23].
A reasonable number of databases has been to interpret the drug mechanism and
their targets as well. DrugBank [24] is bioinformatics-cheminformatics databases that
focus on molecular information about drugs and drug targets with hyperlinks to many
other reliable databases. Comparative Toxicogenomics Database (TCD) [25] advances
the understanding of the effects of environmental chemicals on human health where the
researchers manually curated the relations between chemicals, genes and diseases.
Effort has also been put to create Local LSA models with their local regions
consisting representative samples. T. Liu et al. proposed a Local Relevancy Weighted
LSI method, which distributes the training documents into different classes according the
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relevancy to that class and performs SVD separately. It assigned empirical weights to
each local semantic space according to its contribution to the global space. There exists
tradeoff between different sized local spaces. Large local spaces are capable of
discriminating the documents sufficiently. But the model also may contain several nonrelevant documents creating noise and systemic bias. On the other hand, small local
spaces are less noisy, but observe lack of information in the documents. Hence, there is
an issue of the class size parameter tuning.
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CHAPTER III

Methods
To achieve the main goal of the study, which is to develop a scalable, unbiased
and efficient drug disease interaction network, several important parameters need to be
customized. The parameters include drugs selection for this study as input to the model,
filtering of representative samples of information to define the local region of every
model, generation of local LSA models, complete LSA model by grouping the local
models, and relevance model for clustering the results based on their association values
against the query, validating the network created against the appropriate Gold Standard,
PharmGKB, a manually curated database. Figure 4 describes the procedures to ensure the
quality of the network, with the underlying generated model.

Figure 4 Block diagram representing the workflow to create the literature mining drug
disease network using the proposed local LSA models.
14

Drugs/Chemicals selected based on statistical analsysis are checked for their presence in
PhermGKB, the Gold Standard. Local spaces are created for those selected drugs by
Query Based Sampling; LLSa models a re-created and integrated to form the complete
semantic model.
Drugs/Chemicals selection
Selection of drugs/chemicals is an important criteria for semanic analysis, as a
random selection would introduce redundancy into the model. PubMed database in NCBI
is used to load the abstracts into the textual corpus from which the local models are
generated. So, drugs for the models have been selected from MeSH, a controlled
vocabulary database of U.S. National Library of Medicine in NCBI. Medline references
in PubMed are cited with MeSH keywords for faster and informative searches in the
PubMed database. The distinctive feature of MeSH database is that the terms are
categorized with 16 categories and are organized in hierarchal tree structure. The
hierarchical levels aid to identify too general and too specific MeSH terms. Terms near
the root of the tree are considered too general and the terms near the leaves are
considered too specific. For instance, the MeSH term “Alcohol” at the root level is too
general with lot of branches and term “sugar Alcohols” at the leaf level is too specific.
For the model underlying the drug disease framework, MeSH category
“Chemicals and Drugs” at the root level is chosen which has 16 sub categories at level 1.
Specificity function is modeled earlier in PharmNet from our CVPIA lab to select MeSH
entities that are neither too general nor too specific. It is because of the fact that too
general drug terms will incorporate redundant information into the model and too specific
terms will not be sufficient informative to create a complete model. Statistical studies
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have been done on different levels, depth, documents ratio of MeSH etc. to select the
pharmacological entities, in PharmNet. Drugs derived for PharmNet are incorporated for
this study with the constraint that they are present in the gold standard, PharmGKB.
Presence of selected drugs in PharmGKB is needed to evaluate the performance of the
system. All drug terms form PharmGKB [21] complying within the statistical analysis are
not chosen for this pilot study as they fall under different MeSH categories. Because it
will increase the computational complexity of the process, when it is scaled with more
local models. As the model created, as well as the network is scalable, it can be extended
with added local models which may cover up more PharmGKB drug terms. Fifty three
drugs have been selected for this pilot study from the above mentioned statistical analysis
and PharmGKB’s presence.
The drug entities selected on the above stated criteria are derived under 4
different subcategories at level 1 under the root level “Chemicals and Drugs category”.
The resulting derived subcategories are D01 “Inorganic Chemicals”, D02 “Organic
Chemicals”, D03 “Heterocyclic Compounds and D04 “Polycyclic Compounds”. D01 has
7 drugs, D02 has 20 drugs, D03 has 10 drugs and D04 has 16 drugs. The selected entities
derived under different categories facilitate the creation of local models. The reason is
that the drug entity from each category can define the dynamic feature range for every
local model.
Clustering the biological concept for every model based on concept size
Different biological concepts have varied number of literature data from PubMed.
Having those biological concepts (drugs/chemicals) in the same model will introduce
systemic bias in the model. Concepts having voluminous textual data will be retrieved
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with lower association values as weights will be distributed for too many terms and vice
versa for the concepts with very few textual data. Though it is computationally feasible,
the main drawback of this method lies in its inability to keep relevant concepts in a single
cluster and separate irrelevant concepts into different ones.
Clustering the biological concepts for every local LSA model based on topic
In this way of grouping biological concepts to every model, relevant conceptual
entities are grouped in a single model thereby ensuring higher mutual independence. So,
wrong semantic capturing of terms will be greatly alleviated. But it may undergo the
problem of systemic bias introduced by different sized concepts in the same model. If
the systemic bias can be taken care, it would be a better way to define the concepts for
every local model.
As the systemic bias will be solved (be explained in chapter 2 Methodology
section), local spaces are created by clustering the selected drugs based on topic. Below
Figure 5 shows the Drugs/Chemicals selected from MeSH based on statistical measures
which are to be clustered based on topic.
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Figure 5 Selected drugs from MeSH categories.
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Dictionary creation
Dictionary can be created from the corpus of the selected features but is
computationally expensive as well as will result in too voluminous dictionary. That will
again lead to computational and storage problems. Also, the dictionary terms have to be
domain specific to make the model utilizable to targete audiences. Dictionary, if created
from the corpus, will comprise of too general English vocabulary which will introduce
noise into the model. With all these constraints, multi gram dictionary is created from
MESH terms which will be in the specific biological domain [11]. One gram, two gram,
three gram terms are created for dictionary to ensure the biological meaning preserving as
LSA will treat each word independently which will likely to lose the meaning. It resulted
in 40466 dictionary terms as of year 2013.
Data Extraction
Local spaces, out of which semantic models are to be generated and dictionary
have been defined. Now, each of the local spaces have to be loaded with textual
information. PubMed is the database from where the abstracts are downloaded through
Entrez eutils programming utilities. As data to be extracted is of huge volume, effective
and precise tool to serve the purpose is necessary.
An automated tool is developed to extract the necessary dataset from PubMed into
a normalized database. The developed script is platform independent and is high
computing linux server for maximum efficiency in data extraction. Several input
parameters are configured in this scripted tool which are mentioned in a separate text file.
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The parameters to be specified for electronic data extraction from PubMed are given
below:


URL: This is the URL of the system from where literature data needs to be

extracted. We used the URL http://www.ncbi.nlm.nih/entrez/eutils is the url to be
mentioned in the script from where the data is to be extracted


Database: PubMed is the database in Entrez from where the data has to be

extracted


Starting year: starting year from when the published articles have to be

extracted, depending on the amount of information need by the user has to be
mentioned. I this study, almost all published articles have been extracted starting
from 1950


Ending year: Ending year also has to be indicated. 2012 is the year in this

study


Maximum number of articles: maximum number of articles to be extracted

for each of the entity (Drugs/Chemicals for our case) needs to be indicated; and
this parameter is set to be unlimited.


Block size: The block size of articles fetched from PubMed at a time is

also indicated. A block size of 200 is set according to the NCBI rule.
The tool is designed in such a way that it extracts data at slow speed during office hours
and high speed during non-office hours, weekends and holidays. This is intentionally
done to reduce the data extraction rate during office hours to ensure the safety of
PubMed.
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The dataset for the 53 factors is downloaded from PubMed and stored in MySQL
database. The database construction is based on the following design (see Figure 6).

MySQL Database design:

Figure 6 MySQL database design. Three tables are used to construct the database for the
MeSH-based factors. Factor table contains 53 MeSH factors, field year in table factor is
used to update the recent article for the entity in the database; Factopmid contains
information need to link the factor to PubMed abstracts using PMIDs (unique identifier
of PubMed abstracts); PMIDContent contains information about each abstract.

The database is designed in such a way that all three tables, factor, factorpmid and
pmidcontent are interconnected. Factor and factorpmid are connected through the field
“factorid” where every single drug is identified with unique id. Factorpmid table is a
many to one table where every factorid has many pmids. Tables factorpmid and
pmidcontent are interconnected through field “pmid” where pmid is PubMed id for its
publications. In this way of database design, all title and abstracts for single factor (drug
in this study) are downloaded from PubMed in the same record. This greatly reduced the
storage capacity. Four databases have been created for each local space and data has been
extracted for the corresponding drugs.
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Data extraction for every local space
Traditional LSA model, with all selected drug entities from different MeSH
categories in a single model would be inclined to introduce systemic bias globally
because of data imbalance. This is due to the fact that both too general MeSH terms with
voluminous number of abstracts and too specific MeSH terms with very little number of
abstracts are in a single model thereby weakening the model to be biased towards the
specific drug entities. As a result, very specific drug entities will be retrieved with high
association when the model is queried with allowable disease terms. Creating Local
models with drugs as features from every MeSH category will restrict the bias within the
local model. Further pre-processing of abstracts will also alleviate the local bias, also and
eventually the combined global model will be far free from systemic bias. The following
sections will detail about pre-processing of data. After the feature selection is done for
every local space, data extraction has to be done to load the space with textual data.
Data extraction for the local spaces/classes is done by downloading titles and
abstracts from PubMed, an online free database developed and maintained by U.S. NLM.
Publications in PubMed have been indexed with MeSH terms. It facilitates the complete
data extraction for the MeSH terms selected even if synonym terms are missed in the
request which is being sent to PubMed electronically.
Loading each local space with only information from the particular MeSH
category will limit it with only positive/relevant samples of data with no discrimination
information from other local spaces. Vigna proposed a distributed and large scale latent
semantic analysis using index interpolation; but the resultant model is Global as it fails to
address the discriminative information inside the model. In this study, local models
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themselves are created with class discrimination and then combined to form the global
model. As a result, each local space will not happen to have closely similar data or
information from other classes. It would not be able to capture the higher order semantic
structure of terms when the local LSA models developed out of local spaces are
combined to form the complete LSA model. Balancing each local class with both
positive/relevant samples of data from its own class and also non relevant samples of data
from other classes, which are difficult to be distinguished from relevant data, is of greater
importance. Moreover, in this work, data/information in the form of abstracts are
downloaded from PubMed from years 1950 to 2012. Almost 60 years of research
publications will most likely have redundant information which will be introduced as
noise into the local regions created. So, extracting even the top ranked positive samples
of abstracts from the same class will subjectively eliminate to a greater extent the "noise"
into the space.
It is found that equalizing the local spaces with positive and negative samples of
information resulted in discarding too much of self-information from the spaces if the
statistically selected MeSH terms for that particular class are not too specific.
Subjectively, 70% of class is loaded with self-information, and 30% is loaded with
discriminative information (shown in Figure 7).
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Figure 7 Pictorial representation describing the balance of local spaces with positive and
negative samples of abstracts.

Query Based Sampling
Sampling is the process of extracting relevant abstracts from the available ocean
by filtering out the irrelevant ones. Query Based Sampling of abstracts (QBS) was
introduced for extracting the relevant samples by utliizing LSA. QBS is used to extract
and load each of the four local spaces with most relavant textual. The following section
will provide a detailed analysis about implementation
LSA is used to retrieve the most relevant samples of abstracts from the same class
and non-relevant abstracts from all possible different classes. The foremost reason to
choose LSA for the sampling is that it places the semantically similar abstracts close to
each other in the reduced Eigen space. As a result, non relevant abstracts from different
classes, but similar in concepts with the relevant abstracts, can be captured.
Implementation
Separate databases have been designed for every local space; 4 local spaces are
created with abstracts, in this study from D01, D02, D03 and D04 MeSH categories.
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When tf matrix is generated from the structured corpus of each database, every column
vector is created in such a way that each cell represents the frequency of dictionary terms
in every abstract of every drug entity selected (as an instance, tf matrix generation for
D01 category shown below in Figure 8). Whereas, in usual implementation of LSA, tf
matrix will be generated with every drug as column vector where every cell represents
the frequency of terms in each biological factor. The reason for this structuring of matrix
is that when SVD is applied on tf-idf matrix, semantically related abstracts will be
captured and placed near to one another in Eigen space which will be retrieved on a rank
basis when the model is queried with representative terms from other categories. The top
ranked abstracts, ranking based on their cosine values with the query vector can be
loaded into the local model, where the representative queries came from.
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Figure 8 Diagrammatic representation of tf matrix generation for D01 local space.
A1, A2… An represents abstracts of every drug like Drug1, Drug2, Drug n. Term1, Term 2,
Term 40466 are dictionary terms.
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Tf matrices are generated for other local spaces too in the same way. Tf-idf matrix
is generated and SVD is applied on it. The Encoding matrix U is found to be too sparse
with too many zeros in it. The U matrix has to be dense as it captures the information
based on the patterns of association of data statistically and contains redistributed weights
for every dictionary term given to all the documents. As every column of the original
matrix is weight given to abstract, there exists more than 80% zeros in the matrix before
SVD is applied. It implies that every column has less information, so, LSA cannot
capture higher order co-occurrence of terms leading to the sparseness in the resultant
matrix generated and thereby in the U matrix too. To resolve this issue, abstracts in the
similar context has to be merged together to increase the information or data amount.
Fuzzy c means clustering is used to merge the abstracts by applying clustering on tf
matrix vectors.
Fuzzy c means clustering
Fuzzy c means clustering [28] is used to cluster the abstracts based on their high
membership values. In fuzzy clustering, each point has a degree of belonging to clusters,
rather than belonging to one cluster completely. Thus, points on the edge of a cluster
will have lower membership values to the centroid of the cluster and will belong to that
cluster in a lesser degree when compared to the points in the center of the cluster. The
centroid of a cluster is defined as
Ck =

 W ( x) X
 W ( x)
k

k

Where,
Wk(x) is the coefficient of a point describing the degree of it to be in the cluster k, and is
inversely proportional to the distance from x to the cluster center.
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Initial number of clusters to be given to the fuzzy c means clustering is chosen based on
the volume of abstracts in every drug entity. It is applied on the tf matrix, shown in
Figure 9, so that vectors close to the centroid of any particular cluster will be clustered
together, i.e. abstracts with same concept are merged together (figure shown below).

Figure 9 Diagrammatic representation of tf matrix generation for D01 local space after
clustering. Cluster1, cluster2 cluster n represents abstracts of every drug like Drug1,
Drug2, Drugn. Term1, Term2, .Term40466 are dictionary terms

It is found that some clusters formed are overloaded with abstracts in the same
topic and will have overlapping terms; on the contrary, there are some outlier points
which will have higher degree of membership to varied clusters resulting in less loaded
clusters. Biased clusters will factually introduce into the models, which is greatly
alleviated by the process (Figure 10).
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Figure 10 Block diagram showing the steps taken to load each local space with unbiased
clusters.

Systemic Bias
As every column of tf-idf is a cluster of abstracts, encoding matrix was denser
with no redundant information. Representative query terms for each local model is used
to query the other models and abstracts from top ‘k’ ranked clusters are sampled based
on their dot product between them.
When every local model is defined with sampled abstracts from top ranked cluster
retrieved from other local models, it is found that some of the clusters are overloaded
with data points and vice versa for remaining others. Systemic bias is more likely to be
introduced into the models, as over populated clusters will introduce too much
information, and less populated clusters will leave the model with less information
resulting in imbalance in the local models. Bias for Erythromycin is shown in Figure 11.
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Figure 11 Graph showing varied number of abstracts for every cluster formed.
Example shown for one entity erythromycin; cluster is overloaded with nearly 4750
abstracts and cluster 9 is less loaded with 120 absrtacts.

Balancing clusters to alleviate bias
To resolve this issue, clusters are averaged with approximately the same number
of abstracts by distributing the points in the overloaded cluster to the less loaded ones,
based on their second higher membership values, third higher membership values and so
on. As every cluster is averaged with approximately equivalent number of abstracts as
shown in the below figure, any cluster retrieved from LSA information retrieval
technique will be yielding same amount of information into the querying models.
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Figure 12 Diagrammatic representation of tf matrix generation for D01 local space after
redistribution of abstracts in clustering. cluster1, cluster2 cluster n represents abstracts of
every drug like Drug1, Drug2, Drugn, where every cluster is approximately loaded with
equivalent abstracts. Term1, Term2, …Term40466 are dictionary terms.

Local spaces
Tf-idf matrix is then generated from the tf matrix with equivalent abstract clusters
and SVD is applied on it. Local LSA model is generated for every local space and is
queried with representative terms from other models and top ranked clusters are
retrieved. The abstracts from which the data points in those top ranked clusters are then
loaded into the corresponding queried local space.
Also, care has been taken to create the local spaces with approximately
comparable number of abstracts in every space. As a result, local regions are created
with balanced self-representative information and discriminative information from other
local regions. Local region for D01 category is detailed in the below Figure 13.
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Figure 13 Block diagram showing the creation of final D01 local space (D01 MeSH
category); same procedure is done for other 3 local spaces too. Ranked positive samples
of abstracts are retieved from local LSA model of D01 original space and inserted into
D01 new space. Also, negative samples of abstracts are retrieved from D02 original space
by Local LSA model and inserted into D01 new space.

Query based sampling of abstracts is used to load every local spaces with 30%
undistinguishable negative abstracts from other local spaces through the integration of
LSA. Also, 70% positive abstracts are sampled from own space and loaded into the final
local pace of the class. Eventually, all local spaces are created with most relevant selfinformation and discriminative information.
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Encoding matrix from Local Model Generation and Dictionary reduction
Local models are created by applying SVD on the tf-idf matrix from the newly
created local space and the resultant Encoding matrix U from each of the local models
was sparse. Careful analysis showed that the U matrix has one third of its rows filled
with zeros, and the rows are derived from dictionary terms which are inappropriate to
the feature range selected for the models. Those terms are discarded from the dictionary
which condensed the dictionary size from 40466 to 29915 terms. Further processing of tf
matrix from reduced dictionary by applying SVD generated highly dense encoding
matrix with no sparseness in it.
Complete LSA model from local models created
Let’s say that the encoding matrices generated from the four local models are U1, U2,
U3, U4, and are approximated to U1k, U2k, U3k, U4k in the Eigen space where the column
dimension of each of U matrices is reduced by k. The dimension k is obtained for every
local model by capturing 97% of the information by thresholding their corresponding
singular value matrix S1, S2, S3, S4, so that dimension k is different for each one of them.
As the Encoding matrix Uis from SVD captures all information on term concept basis,
combining encoding matrices from every local model incorporate the needed
information.
Combining Encoding matrices of local models
The global Encoding matrix can be formed by adding the local Encoding matrices
element wise by weighting each element of local encoding matrix by relevance score;
the relevance score is determined by the contribution of a particular model when
combined globally. The problem with this approach is that every local model’s
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Encoding matrix must be of same dimension so that they can be added element wise.
But in our study, as every local space is defined by different number of features which
resulted in different column dimension of the encoding matrices even though row
dimension is same because of the same dictionary.
In the proposed method to create the global encoding matrix, all encoding matrices are
placed parallel to each other as, mentioned above, the dictionary is same for all of them.
Let’s say the encoding matrix for created four local models are to U1k, U2k, U3k, U4k
then, the combined local model would be generated, as shown in Figure 14.

Figure 14 Encoding matrices U1, U2, U3, U4 placed parallel to form the global encoding
matrix; Term 1, … Term 40466 are dictionary terms.
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The shortcoming of this approach is that the columns of the resultant U will not be
orthogonal to each other which are an essential feature to use SVD, as it is supposed to
capture unique information in each of the columns. This is resolved by applying SVD
again on U to decompose it again to U, S, and VT. Now the raw data of each local model,
i.e. columns of tf-idf matrix is projected onto the reduced Eigen space in such a way that
Pi = UTAi where Ai is the tf-idf matrix of each local space. The global matrix P = [P1 P2 P3
P4] is created which can be queried with queries projected onto reduced Eigen space (Qp
= UT Q). The retrieved results for the query are ranked based on cosine similarity
measure between the projected query vector Qp and every column of P. As the systemic
bias due to varied sized documents (Drugs/Chemicals here) has been taken care of during
Query based sampling, cosine similarity measure is used to measure the similarity
between the projected query vector and each column vector of P and the results are
retrieved in ranked order.
Relevance Model
As LLSA model is scalable, more features (Drugs/Chemicals in this study) can be
added, as a result, evaluation of the model with queries which have voluminous relevant
set would be accomplished. So, it is imperative to verify whether the model is capable of
pulling high precision in the top ranked result or highly relevant set, when it is scaled.
The similarity measure, cosine value in this study ranges differently for different queries,
as it is data driven. Hence manual thresholding to determine the highly relevant set is not
feasible for every single query. So, a relevance model is developed, to automatically
cluster the retrieved results into three groups like highly relevant results, moderately
relevant results and low relevant results. Fuzzy c means clustering [28] is used to cluster
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the cosine values of retrieved drugs/chemicals for every query. The whole set of retrieved
Drugs/Chemicals for every query is categorized into three groups such as highly relevant
set, reasonably relevant set, and poor relevant set.
DDNet: A Drug-Disease Interaction Framework and PubMed Link Tool
Tremendous growth in biomedical literature as a consequence of experimental
and computational biomedical data drove the scientific community to develop literature
mining web tools to find the nuggets of information most relevant and useful for specific
analysis tasks. The ultimate goal of this study is to aid the research community to
browse through the Drug-Disease associations.
So, a fully integrated, interactive, user friendly, web based framework DDNet is
developed and deployed. The underlying LLSA model is used to explore the associated
Drugs/Chemicals for any given user query, thereby facilitating the information retrieval.
It is broad enough to accept multi gram MeSH terms as queries with the options of
visualizing the results based on the intensity of information need. The semantically
extracted associated factors are ranked in order based on the similarity measure between
the user query and factors in concept level.
Additionally, the ranked factors are clustered as highly relevant set, reasonably
relevant set and poorly relevant set as an outcome of Relevance model.
DDNet users have the comfort of seeing narrowed down results depending on the
options chosen by them. Naïve users, who want to gain the basic knowledge about drugdisease interactions, might be settled down with highly relevant set, medical researchers
or pharmacists might broaden their knowledge with reasonably relevant or poor relevant
result set for deeper analysis and thoughts. Uncovering of Knowledge Discovery in the
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course may smooth the researcher’s progress of generating new hypothesis, which will
ease the Drug repositioning, for which this framework is studied and developed.
The user interface of DDNet is show in Figure 15 and the ranked results from the
webtool is shown in Figure 16.

Figure 15 User interface of DDNet to enter queries.
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Figure 16 The display of ranked Associated Drugs/Chemicals for the user query
Alzheimer disease.
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In the DDNet display shown above, the user is displayed with ranked highly
relevant set of associated drugs/Chemicals for his query, based on his option of relevance
chosen. The time scaled for the user to analyze the results is reduced as it is clearly
ranked in the flat file. A plethora of web tools are developed by the research community
in biomedical domain with interactive interfaces. As an instance to note, [29] developed a
single graph theoretic framework for all known phenotype and disease gene associations
which are represented by nodes and edges. In this framework, disorders are represented
by nodes which are interconnected with edges; genes are represented by edges with their
thickness dente the number of genes in the interconnection.
The interface of DDNet displays the results with ranks which are comparatively
easier for the users to analyze rather than analyzing the thickness of edges. Future
direction of this work is to expand this framework with increased Biological concepts,
allowing multiple queries from the users, displaying the graphical display with
interconnected concepts between those queries as edges with queries as nodes.
Implementation details using software languages
The entire web tool is programmed using the object oriented language core java,
which is beneficial [30] for the model generation and computing similarity measure
between the queries and the biological concepts (Drugs/Chemicals here), Java enterprise
technologies for web implementation and MATLAB for handling matrix computations
beneath the model.
Reasons for java:


The main reason for utilizing java is that it is a well suited programming

language to develop highly interactive Graphical user interfaces.
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It is platform independent and can be run in any other operating systems in

spite of the fact it is programmed in windows.


Java scripts which are extended nowadays to generated graphical displays

where java script objects can be stored as JSON objects and be displayed in nodes
and edges


As future work is intended to graphical network display, java is the well

suited programming package to use
Java usage: The front end interface, i.e. query entry and results displays are done with
Java server pages, a JEE technology as static pages can be made interactive by bundling
them inside java code. Similarity measures are computed in core java by creating Matrix
classes and corresponding methods such as transpose multiplication etc. to deal with
matrices.
MATLAB usage: The structured data is converted into meaningful numbers though tfidf matrix generation and LSA model is created by applying MATLAB in built function
SVD.
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Efficiency of the framework as a result of Pre-computed results
DDNet is very time efficient in retrieving the associated information to the user.
For instance, the time taken to retrieve the associated drugs/chemicals to the users query
“Alzheimer disease” is just a couple of seconds. The reason behind this time efficiency is
that the results are pre-computed for all 29915 dictionary terms (please see section 3.8 for
details) which can be given as queries to this network. The associated Drugs/Chemicals
for any query is found by cosine similarity between them and ranked in order by sorting.
HashMap: Java has been useful in pre-computation part also as the language has tables to
store apart from arrays to directly retrieve the required information by indexing.
HashMap is one such useful mapping table which allocated separated buckets for each of
it collections. HashMap is used over HashTable, which is also a similar package from
where HashMap is derived, because HashMap allows null values. The extracted
associated drugs/chemicals for some of the queries from DDNet are null as they do not
have any associations semantically. So HashMap is the reliable procedure to store the
results for our case.
The extracted results for each of the possible queries within the dictionary range
are loaded into a hash map with every dictionary term as key and array of its associated
concepts as values. When the user hits a query to this web tool, it index the corresponding
key and fetch the values for that key and displays it in ranked order based on their
similarity measure. As HashMap does not have to iterate through the key collections, and
directly index it from the bucket, the time taken to retrieve the results is comparatively
less. The framework developed will be time saver for the users as they do not have to
wait for seeing the displays as they have to do in front of the frameworks which compute
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the results on the fly. This is one of the key advantages of the developed framework
DDNet.
Subjective analysis has been conducted on ranking of associations between drugs
and disease of DDNet by analyzing the results with published articles for its factualness.
Network of Drug-Disease association from DDNet using MeSH hierarchal code
Network of Drug-Disease associations can be derived from DDNet framework
utilizing hierarchal structure of MeSH, from which the domain specific dictionary is
created by Ontology mapping [11]. The associated Drugs/chemicals from DDNet, for a
disease query can be represented as hierarchal tree by Reverse mapping onto MeSH
ontology to the root level. Combining multi queries with their retrieved semantically
associated concepts with their tree structure will result in network of interconnected
objects through Drugs/chemicals. This hierarchal structure network will be categorically
useful for the Pharmacists to derive the hierarchy of drugs/chemicals from which he/she
can gain knowledge about the chemical composition of drugs as well as associations
between drugs though the diseases. As the results are classified as highly, reasonably and
poor relevant set, networks can be derived based on the intensity of information need. As
an instance, highly relevant set of Drugs/Chemicals retrieved for queries Alzheimer
disease and Cardiovascular disease are shown as interconnected network in Figure 17
with their reverse mapping onto MeSH ontology.
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Figure 17 Network of Associations of Drugs/Chemicals for diseases Alzheimer disease
and myocardial infarction derived from MeSH hierarchy.

In the above network, semantically related Drugs/Chemicals for disease
Alzheimer disease and Myocardial infarction are shown with their reverse mapped MeSH
hierarchal structure, back to the root level. It might facilitate the Pharmacists to derive the
chemical composition of the drugs thereby analyzing its uses for other diseases or targets
apart from what they have been produced for. Also, this network shows that Alzheimer
disease and Myocardial infarction are related through Metoprolol, which detailed about
the usage of it.
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Future Directions in DDNet: Network of Drug-Disease associations are to be developed
automatically from the retrieval of DDNet would be accomplished in future to make this
tool a complete and informative framework.
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Chapter IV

Results and Discussion

Drug-Disease Association
An efficient, robust, scalable and unbiased model for finding the network of
semantically related drug-disease associations is built and user friendly interface, DDNet
is developed to display the associations in readable manner. LLSA is designed and
implemented to achieve this goal. Semantically related associations can be derived from
published literature, where huge amount, biological results are preserved as result
discussion. A brief overview about the procedure implemented is described below.
Statistical analysis on MeSH terms resulted in 53 drugs/chemicals for this study,
and are derived under D01, D02, D03 and D04 MeSH categories. Four local spaces have
been defined from the four derived MeSH categories. Textual data has been extracted
from PubMed for 60 years for the drugs in each of the local spaces. Around 0.2 million
abstracts have been extracted for D01 original local space. Aroung 0.3 million abstracts
have loaded into D02 original local space. Approximately 0.15 million abstracts have
been extracted for D03 original local space. Approximately 0.25 million abstracts have
been extracted for D04 original local space.
Multi gram dictionary is created by the combination of MeSH terms to preserve
the biological meaning in the literature when it is modeled.
The local spaces are defined with well relevant representative samples of abstracts
from own as well as varied classes to balance the region, through Query Based Sampling
method (described in section 3.6 for details). Also, care has been taken to distribute
equivalent volume of information in each of the spaces thereby reducing the bias.
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Out of 2,04,617 abstracts in D01 original space, 1,35,387 abtracts have been
retrieved as relevant samples by QBS and loaded into D01 new local space. Around 69,
000 abstracts have been retrieved from other local spaces such as D02, D03 and D04. Out
of 2,70,090 abstracts in D02 original local space, 1,89,063 abtracts have been retrieved as
relevant samples by QBS and loaded into D02 new local space. Approximately 81,000
abstracts have been retrieved and loaded into D02 from other local spaces such as D03,
D01 and D04. Out of 1,52,599 abstracts in D03 original local space, 1,06,000 abtracts
have been retrieved as relevant samples by QBS and loaded into D03 new local space.
Half a million abstracts have been retrieved from other local spaces such as D01, D02
and D04. Out of 2,55,369 abstracts in D04 original local space, 1,78,758 abtracts have
been retrieved as relevant samples by QBS and loaded into D04 new local space. Ten
percent of million abstracts have been retrieved from other local spaces such as D01, D02
and D03.
With the dictionary of size 40466 created and local spaces defined, Local LSA
models are created from each of the local spaces. As the encoding matrices are very
sparse with zeros in it, irrelevant dictionary terms in those aerp row indeces are discarded
resulted in a reduced dictionary od 29915 terms. LLSA models relieve the system to a
major extent from bias, scalability issue; the traditional global model suffers.
This chapter describes about the objective evaluation of the LLSA in finding the
associations which is underlying the interface. A number of empirical studies have been
conducted to study about the system’s efficiency, scalability, bias and robustness which
concluded the overall performance of the system.
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Efficiency
To ensure about the efficiency of the network, time taken for the LLSA system to
retrieve the associated Drugs/Chemicals with the supportive evidence of PubMed IDs
links for any user query is noted down. The results are pre-computed for all the possible
29915 queries, stored in Hashtable and, can be extracted by indexing when the system is
queried (Please see Section 3.11for details). As a constructive consequence of precomputation, the observed time taken by the system for a query is approximately
25milliseconds which is far less than any other system which computes the results on the
fly. Hence, pre-computation greatly enhanced the efficiency of the system which is one
of the parts of the goal in this study.
Systemic Bias
Systemic Bias, which is a general occurrence in Global LSA model, is greatly
lessened by Query Based Sampling of Abstracts (see section 3.6 for details). Every LLSA
model is created with approximately equivalent amount of information so that each of the
retrieved concepts is predicted to have association values within narrow range for any
given query. Cosine similarity values, which yielded the association, are analyzed for the
LLSA model’s non-biasedness. Cosine values for associated Drugs/Chemicals for the
Query “Alzheimer Disease” are taken for analysis and are plotted for comparison with
the values from Global LSA model (see Figure 18).
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Figure 18 Graphical representation of the distribution of cosine values for the
semantically associated Drugs/Chemicals for the Query Alzheimer disease; shown for
both Global and Local LSA models.

From the above graph, it is evident that cosine values for Local LSA model fall
within a very narrow range, whereas cosine values for Global LSA model fall within a
comparatively wider range. For LLSA model, the maximum of the cosine values is
0.0903 and the minimum is 0.0071 with standard deviation of 0.024, whereas for
Global LSA model, the maximum of the cosine values is 0.6547 and the minimum is
0.0191 with standard deviation of 0.153. Lower standard deviation obtained for LLSA
implied that the vectors of cosine values of semantically related Drugs/Chemicals for the
query “Alzheimer disease” are placed near to each other. This meant that all the retrieved
Drugs/Chemicals contain approximately amount of derived useful information in the
model from the corpus and eventually resulted in a bias free model. For Global LSA
model, the standard deviation of cosine values is higher which implied that
48

Drugs/Chemicals with voluminous amount of information are retrieved with lower cosine
values and those with less information are retrieved with higher cosine values. This
clearly indicated that Global LSA model is inclined to bias.
LLSA is relieved from systemic bias by Query Based Sampling of Abstracts
which loaded the local spaces with equivalent amount of positive and negative samples of
information. Cosine values of associated retrievals for other queries are given in
Appendix section for further analysis.
Scalability
In Global LSA model, all the features selected from MeSH terms, for this domain,
have to be incorporated into a single model, which would result in bulky amount of
textual data. The computational complexity is high as the model has to be computed from
a very high dimensional tf-idf matrix. Even, loading of very high dimensional matrix into
MATLAB for further computations is infeasible as MATLAB is restricted with
40000X5000 matrixes. Concluding, Global LSA model is not scalable because of
computational complexity.
The proposed model is scalable as MeSH terms can be incorporated into it as
unique local models. The added features are localized into separate models with limited
textual data in each of the local spaces. Hence, tf-idf matrices generated from each of the
spaces is of low dimension and thereby compatible to be computed in MATLAB for
model creation. LLSA has an added improvement of scalability over traditional Global
LSA model.
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Robustness
Recall and Precision curve/PR curve [10], the standard measure to determine the
effectiveness of an information retrieval system are used to evaluate the robustness of the
IR system developed. The results are retrieved from DDNet, an LLSA system, and to
look how precision varies for every recall, a Gold Standard is needed to evaluate the
retrieved results against the relevant.
PharmgGKB: The Pharmacogenetics and Pharmacogenomics Knowledge Base,
PharmGKB [19], a manually curated comprehensive database is used as Gold standard to
validate the web tool developed. It is a web based public repository of genotype and
phenotype information relevant to pharmacogenetics, developed at Stanford University
with the funding from NIH. It has varied data from research, clinical outcome etc. to
catalyze the research in the field of Personalized medicine. It had an Excel file with
relationships between drug-drug, drug-disease and disease-gene, which is downloaded in
2012 to evaluate the performance of the system.
Query selection for validation and evaluation
Queries, used to plot PR curve is an important parameter as random selection
without sufficient relevant set would result in incorrect low recall. So, they are carefully
selected based on relevant drugs/chemicals which are common in both the model and
PharmGKB, the Gold Standard, used for validation. If subset from relevant set of results
for any particular query is present in the model, then that particular query is selected for
validation purposes. If none of the relevant results for a query is present in the model,
validating the system with that query would be unfair and also will end up in zero recall
and precision. In the Figure 19 shown below, query 1 is selected for validation as part of
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relevant set of drugs/Chemicals is in the model also and Query 2 is discarded as there is
no common items. This resulted in the selection of 20 queries.

Figure 19 Diagrammatic representation for selection of queries to validate the model.
Query1 is selected and Query2 is discarded.

Also, care has been taken that selected queries are not random so that the model
could have been analyzed for its performance by queries falling under specialized
categories of diseases. This categorized query selection will formulate the model to be
credible and complete enough for any specific medical set. Yet again, with inclusion of
more biological concepts (Drugs/chemicals in our case), the model can be enhanced to
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be complete enough for extended medical groups too, thereby generalizing the network
developed. Twenty queries selected fall under 4 broad categories such as Heart related
diseases (Figure 20), Brain related diseases (Figure 21), cancer related disease (Figure
22), Lung related diseases (Figure 23).

Figure 20 Queries categorized under heart related diseases.

Figure 21 Queries categorized under brain related diseases.

Figure 22 Queries categorized under cancer related diseases.
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Figure 23 Queries categorized under lung related diseases.

PR Curve and Analysis
As the results are retrieved in rank order from our system, for any user query,
recall and precision can be calculated for each set of top k retrieved items
(drugs/chemicals in our study) and precision-recall curve can be plotted for each set.
For a single query, if an item added is relevant both recall and precision will increase
and if the added item is not relevant, recall will remain the same and the precision will
decrease. Hence the PR curve would follow a saw tooth shape with too many jiggles in
it. To remove these jiggles and to interpret the PR curve effectively, precision is to be
calculated only whenever there is an increase in the recall. The judgment is that user
would be ready to look at few more items if it would increase the percentage of the
retrieved set which is relevant. The traditional way of doing this is 11 point average
precision. For every query, precision has to be calculated at 0.0 0.1 0.2 0.3 0.4 0.5 0.6
0.7 0.8 0.9 1.0 recall levels. For multiple queries, average precision is to be calculated
for each query for 11 point recall levels and the PR curve can be plotted for analysis. To
analyze the PR curve evidently, 11 point averaged precision-recall curve is plotted for
multiple queries, shown in Figure 24.
Factually, if the size of the relevant set for any query is huge, the retrieved
relevant set from the system will be distributed with slowly decreasing precision for
increasing recall rates. So, as an initial step, all the retrieved Drugs/Chemicals for each
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of the above selected 20 queries are taken into account and average precision of all
queries has been calculated and plotted for every recall rate.
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Figure 24 Averaged 11 point Precision/Recall graph plotted across selected 20 queries. The
results were obtained from DDNet.
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Precision gradually decreases with increase in recall, except for recall level of 0.5,
which shows the consistent performance, i.e. robustness of the underlying Local LSA
model of the system as relevant results are retrieved at approximate regular intervals. It
can be seen that the precision at recall rate of 100% is little higher because there are few
queries which has only one relevant drug/chemical present in the model; so, precision
goes to 1 when recall increases from 0 to 1. Another important observation from the
validation is that except for two queries like Asthma and Alzheimer disease, recall is
100%.
Generally, for any IR system, Recall and Precision are important over one
another. For instance, web surfers would like to see only relevant items in their first
page and may not be interested to know about every relevant item possible, i.e. high
precision even at low recalls, whereas researchers would like to see almost all relevant
items possible with the tolerance of having some false positives, i.e. high recall with low
precision. Hence, Recall and Precision values need to be high based on the information
need of the user. For the utilization of the network developed specifically for some
domain specific researchers, high recall is expected even with little less precision.
As this work and the developed web tool and Network visualization intends to facilitate
the researchers in this domain and medical specialists, it is imperative for the model to
retrieve the relevant results as much as possible, so that the specific users can gain the
complete knowledge about their information need. Thus, 100% recall retrieved by our
LLSA system validated that the system is accurate for domain specific researchers as all
relevant results are retrieved from the model which most researchers/medical experts
would be longing to look for.
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Mean Average Precision
A single measure of quality to trade off precision versus recall for ranked results is
Mean Average Precision. Average precision is the arithmetic mean of precision values
obtained for the set of top k retrieved documents for every increase in recall and this
averaged precision is again averaged over all possible queries.
m

1 |Q| 1 j
Mean Average Precision, MAP (Q) =
  Pr ecision( R jk )
| Q | j 1 m j k 1
Where,
qj - every single jth query
dmj - set of relevant documents
Rjk - set of ranked retrieval results from the top result until it gets to document dk
For a single query, average precision approximates the area under the PR curve and so
MAP is the average area under the PR curve for the set of queries. Using MAP, recall
level is not fixed, so each information need/query is given equal weighting as some
queries have many relevant results and some may have very few relevant results. So,
recall level will be different for different queries. MAP is calculated just as the average of
arithmetic mean of precision values of every query for their individual recall levels.
Selected 20 queries have different recall levels from our model also, so, MAP would be
the appropriate choice as the single figure measure of quality. MAP for the model and
thereby the system developed is 0.2331. To ensure whether the obtained MAP value is
rationally a good figure, Mean Average Precision of Global LSA model is computed and
checked with the value gotten from Local LSA model.
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Comparison of the performance of Global LSA model and Local LSA model
To determine the better performance of the Local LSA model, its performance is
compared with the Global LSA model. The same 53 drugs from 4 different MeSH
categories are chosen and data/abstracts are extracted from PubMed to define the global
space and the global model is created from the space as it is described in section 1.1. The
selected 20 queries are used and average precision across all queries is plotted for 11
point recall rates, shown in the below figure.
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Figure 25 Averaged 11-point Precision/Recall graph plotted across selected 20 queries
for Local LSA model and Global LSA model.
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From the above PR curve, it can be seen that PR curve varies a lot for Global LSA
model showing the inconsistent behavior of the model. The curves revealed clearly that
LLSA model is robust than Global LSA model. Also, the precision is comparatively low
at recall rate of 1 which again indicates that the model could not retrieve the relevant
drugs/chemical for those queries with only one relevant result from the Gold standard, as
it could be remembered from section 4.1. It could be clearly stated that Global model
could not result in a recall of 100% for many queries as it was the case in Local LSA
model. Again the PR curve made evident that LLSA is more an appropriate model to
retrieve more relevant results for researchers. Also, MAP for Global LSA model is
0.1874 which is approximately 5% less than MAP of Local LSA model. Though the
improvement is very minuscule, it shows that little improvement in the developed model
over the traditional Global LSA model.
Future Directions: As the above analysis is based on a pilot study with very less amount
of Drugs/chemicals in the Local model, many relevant items from PharmGKB, the Gold
Standard are not included. It is very evident that the model showed less precision as
relevant items cannot be retrieved because of their non-existence in the model. If the
Local model developed could be optimized with much more Drugs/chemicals, it can be
indubitably expected that its performance would be higher with higher precision.
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Performance evaluation of the Local LSA model developed against Local LSA
model without Query Based Sampling of abstracts
While generating the Local LSA models, local regions are shaped up with much
care so that it is packed with self-representative information from its own space and
discriminative information from other local spaces. Query based sampling of abstracts,
described in 3.6 is used to define and classify each of the local space. Each local model
developed is an outcome from the local spaces defined, sampled abstracts, through Query
Based Sampling, from their own region and other regions play a vital role in the models
generated. To check whether the essence of Query Based Sampling is a merit or demerit
for the model, the performance of the developed model is being been compared with
Local LSA model developed without Query Based Sampling using PR curve (see Figure
26).
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Figure 26 Averaged 11-point Precision/Recall graph plotted across selected 20 queries
for Local LSA model which has representative information and local LSA model which
does not have representative information.

From the above graph, the Local LSA model with sampled abstracts from its own
class as well as from other classes is comparatively stable than the local LSA model with
sampled representative abstracts. MAP for the Local model, where the Query based
sampling of abstracts is not utilized to load the textual information is 0.20234 which is
also 3% less than the proposed Local LSA model. So, Query based sampling of abstracts
to define the space of local model is a positive incorporation for the model as the noise is
greatly reduced and resulted in robust model. To make a comprehensive analysis about
the robustness of the models, PR curve is drawn and compared for the local LSA model

60

with representative abstracts, local LSA model with all possible abstracts and Global
model and is shown below. It is very apparent that LLSA model developed is robust
compared to other two models from the Figure 27.

Figure 27 Averaged 11-point Precision/Recall graph plotted across selected 20 queries
for LLSA model with representative information, LLSA model with all possible
representative information and Global LSA model.
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Performance Evaluation based on the degree of relevancy of retrieved results
As LLSA model is scalable, more features (Drugs/Chemicals in this study) can
be added, as a result, evaluation of the model with queries which have voluminous
relevant set would be accomplished. So, it is imperative to verify whether the model is
capable of pulling high precision in the top ranked result or highly relevant set, when it is
scaled. The similarity measure, cosine value in this study ranges differently for different
queries, as it is data driven; hence manual thresholding to determine the highly relevant
set is not feasible for every single query. So, a relevance model is developed, to
automatically cluster the retrieved results into three groups like highly relevant results,
moderately relevant results and low relevant results. Fuzzy c means clustering [28] is
used to cluster the cosine values of retrieved drugs/chemicals for every query. The whole
set of retrieved Drugs/Chemicals for every query is categorized into three groups such as
highly relevant set, reasonably relevant set, and poor relevant set. The same 20 queries
are used to analyze each of the relevant set.
Subjective analysis is done on each of the relevant set to discover whether the
False Positives retrieved by the model are factually incorrect or they are not captured by
the Gold Standard as relevant.
Highly Relevant Set
As it is expected, larger number of relevant results from the Gold standard is
retrieved as the top ranked associated results for any selected query. As a consequence,
average precision of the results for each of the query is elevated than the average
precision when all retrieved results are taken into consideration and eventually MAP
came up to 0.534.
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The model created has higher recall in highly relevant set as well as it extracted some
results which were irrelevant against PharmGKB. But when the results, drug-disease
associations were checked manually they were discovered to be relevant in published
literatures. As an instance, for query Alzheimer disease, Vitamin E is retrieved as highly
relevant Drug/Chemical, as shown in Figure 28 which is not captured by PharmGKB.
[31] Showed that the intake of Vitamin E exhibits the pronounced protective effect of
Alzheimer disease.

Figure 28 Screen shot showing the highly relevant set with Vitamin E at ranks 5 for the
query Alzheimer disease.

Reasonably relevant set
MAP for reasonably relevant set came up to 0.17 which is significantly less than
MAP for highly relevant set (0.534). This implies that comparatively, more number of
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relevant results is retrieved in the top ranked set with high association values, than the
number of relevant results with moderate association values. Magnesium came as
reasonably relevant associated chemical from DDNet (Figure 29) which is not a relevant
result for Alzheimer disease from PharamGKB. [32] Studied the effects of altered
magnesium levels in mild-moderate Alzheimer disease which strongly proved that
magnesium level has high impact in Alzheimer disease.

Figure 29 Screen shot showing the reasonably relevant set with magnesium at rank 5 for
the query Alzheimer disease.

Poor Relevant Set
MAP for reasonably relevant set came up to 0.12 (Figure 30). [33] Suggested
considering vitamin K in future investigations on the role of diet in Alzheimer's disease.
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Figure 30 Screen shot showing the poor relevant set with vitamin K at rank 11 for the
query Alzheimer disease.

From the MAPs obtained for the above three relevancy sets of results, it is proved
that Local LSA models generated for DDNet, is capable of retrieving relevant items as
the top ranked results which enable any common users to gain some fundamental
knowledge about the related Drugs/Chemicals based on their information need. Also, as
described in section 3.1, recall for almost all selected queries is 100% which enables the
specific users like medical researchers to gain thorough knowledge about their
information need. Also, some of the results which came as top ranked results but not
within the highly relevant set and not published can be meticulously taken as Knowledge
Discovery and be used for further research. Additionally, as the network is scalable to
include lot more domain specific biological entities, precisely Drugs/Chemical here,
higher Mean Average Precision can be expected for the Highly Relevant Set. Also, for
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the retrieved results which are not relevant from the Gold standard, PharmGKB, above
mentioned citations have proofs that they are relevant; i.e. results which are extracted as
false positives are actually not false from the above mentioned citations. Even an
associated Drug/Chemical for the query in the poorly relevant set seems to be fairly
correct as per the citations.
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Chapter V

Conclusion

This study was set out to explore semantically related drug-disease associations,
to expedite the application of drug repositioning, by implementing information retrieval
technique, LSA, on noise free literature from PubMed. This study also sought to develop
a scalable, robust, efficient and bias free framework DDNet, to rank the associations
retrieved from LSA model, for user query, thereby facilitating the medical researchers to
get forward in their goal. Query Based Sampling of abstracts is executed to filter the
garbage from literature data and Local LSA models are created from the filtered data to
ensure the scalability and robustness in the framework. LLSA incorporated on sampled
textual data resulted in robust semantic model which is evident from PR curve analysis
for selected twenty queries. PR curve analysis showed the robust nature of the proposed
LLSA model and thereby DDNet itself. MAP was computed to be 0.2331 which is
approximately 5% greater than the traditional semantic model. Even, the retrieved
associations from the model which are not relevant are substantiated for its correctness
through Medline citations from the subjective evaluation.
The scale of this study is limited with 53 features, but the LLSA model is
generated as scalable. To achieve the complete usability of the proposed model and
framework, by the medical experts and researchers, higher recall and precision is one of
the chief aspects to be targeted. This can be achieved by incorporating more sampled
features into the system at the local model level which will retrieve all possible relevant
results.
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This work has offered an accurate semantic model over traditional LSA model in
the application of Drug repositioning and was conducted on specific domain of drugdisease network. The model can even be scaled with varied biological concepts as
features to spread the usage; like facilitating the hot topic Personalized Medicine [34] by
inclusion of genes.
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Appendices

A. Associated drugs/Chemicals for 20 selected queries for Local LSA model with
sampled information (Proposed Methodology)

Alzheimer disease

galantamine, metoprolol, memantine, isoproterenol, epinephrine,
nitrous oxide, tacrine, aldosterone, nitroprusside, digoxin,
betamethosone, nicotine, morphine, triamcin, beclome,
hydrocortisone, codeine, estrone, testosterone, budenoside, ethinyl,
lithium, warfarin, levonorgestrol, pravastatin, nore, methadone,
magnesium, lovastatin, tamoxifen, mifepristone, acetaminophen,
zinc, dicloxacillin, copper, macrolides, prednisolone, erythromycin,
amoxicillin, vitamine, curcumin, tacrolimus, sirolimus,
cyclosporine, ritonavir, prednisone, troleandomycin, calcitriol,
vitamink, mycophenolic, cisplatin, vincristine, idarubicin

Neurodegenerative

tamoxifen, cisplatin, testosterone, curcumin, memantine, estrone,

disease

galantamine, calcitriol, nicotine, mifepristone, idarubicin, sirolimus,
epinephrine, isoproterenol, vincristine, nitroprusside, vitamine,
tacrine, morphine, zinc, cyclosporine, magnesium, macrolides,
hydrocortisone, tacrolimus, triamcin, copper, vitamink, ethinyl,
prednisolone, lithium, lovastatin, aldosterone, nore, betamethosone,
prednisone, pravastatin, metoprolol, troleandomycin,
mycophenolic, levonorgestrol, codeine, erythromycin, beclome,
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ritonavir, dicloxacillin, budenoside, warfarin, acetaminophen

Dementia

memantine, galantamine, nicotine, nitrous oxide, tacrine, copper,
epinephrine, isoproterenol, morphine, zinc, lithium, methadone,
magnesium, troleandomycin, vitamine, curcumin, metoprolol,
vitamink, nitroprusside, mifepristone, acetaminophen, beclome,
triamcin, budenoside, cyclosporine, sirolimus, macrolides,
calcitriol, hydrocortisone, betamethosone, lovastatin, tacrolimus,
digoxin, erythromycin, testosterone, codeine, ritonavir, aldosterone,
warfarin, ethinyl, tamoxifen, nore, pravastatin, estrone,
levonorgestrol

Drug Toxicity

vincristine, warfarin, digoxin, idarubicin, prednisone, cisplatin,
mycophenolic, curcumin, prednisolone, lovastatin, tacrolimus,
cyclosporine, pravastatin, ritonavir, triamcin, sirolimus,
acetaminophen, vitamink, isoproterenol, nitroprusside, metoprolol,
nitrous oxide, macrolides, betamethosone, budenoside, codeine,
vitamine, morphine, erythromycin, amoxicillin, epinephrine,
dicloxacillin, beclome, calcitriol, troleandomycin, lithium,
tamoxifen, aldosterone, magnesium, mifepristone, hydrocortisone,
tacrine, copper, zinc, testosterone, ethinyl, memantine, nicotine,
estrone, galantamine, nore, levonorgestrol
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Transplantation

prednisone, mycophenolic, prednisolone, triamcin, tacrolimus,
metoprolol, beclome, warfarin, cyclosporine, amoxicillin,
vincristine, nitrous oxide, betamethosone, budenoside, idarubicin,
digoxin, erythromycin, macrolides, dicloxacillin, ritonavir,
vitamink, sirolimus, acetaminophen, aldosterone, magnesium,
cisplatin, pravastatin, hydrocortisone, nitroprusside, lovastatin,
lithium, zinc, troleandomycin, methadone, copper, vitamine,
epinephrine, levonorgestrol, calcitriol, ethinyl, memantine, codeine,
nore, isoproterenol, galantamine, tamoxifen, nicotine, mifepristone,
testosterone, morphine, tacrine, estrone, curcumin

Depression

memantine, nicotine, galantamine, lithium, testosterone, zinc,
isoproterenol, epinephrine, tacrine, tamoxifen, mifepristone, copper,
estrone, magnesium, morphine, methadone, vitamine, nitroprusside,
hydrocortisone, nore, troleandomycin, calcitriol, ethinyl,
metoprolol, sirolimus, aldosterone, vitamink, curcumin, codeine,
lovastatin, levonorgestrol, digoxin, acetaminophen, cyclosporine,
macrolides, cisplatin, pravastatin, tacrolimus, nitrous oxide,
betamethosone, triamcin, erythromycin, idarubicin, ritonavir,
budenoside, beclome, mycophenolic, vincristine, warfarin,
prednisolone, prednisone, dicloxacillin, amoxicillin

Venous thrombosis warfarin, metoprolol, triamcin, prednisone, vincristine, beclome,
idarubicin, prednisolone, pravastatin, mycophenolic, nitrous oxide,
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galantamine, digoxin, betamethosone, aldosterone, memantine,
methadone, epinephrine, budenoside, cyclosporine, tacrolimus,
cisplatin

Thrombosis

warfarin, acetaminophen, curcumin, vitamine, beclome, vitamink,

embolism

mycophenolic, prednisolone, budenoside, cisplatin, prednisone,
lovastatin, digoxin, triamcin, pravastatin, ethinyl, levonorgestrol,
amoxicillin, metoprolol, tacrolimus, lithium, betamethosone,
codeine, idarubicin, cyclosporine, vincristine, nore, erythromycin,
nitrous oxide, tamoxifen, macrolides, memantine, sirolimus,
troleandomycin, ritonavir, methadone, magnesium, tacrine,
hydrocortisone, nicotine, aldosterone, copper, nitroprusside,
isoproterenol, estrone, testosterone, dicloxacillin, morphine,
galantamine, mifepristone, calcitriol, epinephrine, zinc

Breast neoplasm

aldosterone, pravastatin, lovastatin, tacrine, nitroprusside,
metoprolol, vitamine, isoproterenol, epinephrine, magnesium,
testosterone, vitamink, morphine, tamoxifen, curcumin,
hydrocortisone, troleandomycin, memantine, amoxicillin,
mifepristone, codeine, levonorgestrol, nicotine, sirolimus, calcitriol,
erythromycin, macrolides, digoxin, warfarin, estrone, zinc, nore,
galantamine, cyclosporine, methadone, tacrolimus, lithium,
idarubicin, budenoside, acetaminophen, betamethosone, ethinyl,
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beclome, prednisone, mycophenolic, prednisolone, ritonavir,
cisplatin, triamcin, copper, dicloxacillin, vincristine, nitrous oxide

Hypertension

mycophenolic, nitrous oxide, prednisone, cyclosporine, lithium,
tacrolimus, prednisolone, magnesium, aldosterone, vitamink,
warfarin, metoprolol, nitroprusside, triamcin, beclome, ritonavir,
sirolimus, acetaminophen, zinc, macrolides, hydrocortisone,
idarubicin, vitamine, pravastatin, digoxin, calcitriol, budenoside,
codeine, betamethosone, memantine, lovastatin, isoproterenol,
epinephrine, ethinyl, troleandomycin, nore, vincristine,
erythromycin, amoxicillin, levonorgestrol, methadone, tamoxifen,
copper, dicloxacillin, estrone, galantamine, testosterone, morphine,
mifepristone, cisplatin, nicotine, tacrine, curcumin

Nausea

codeine, morphine, acetaminophen, methadone, digoxin, cisplatin,
tamoxifen, curcumin, estrone, nicotine, testosterone, ethinyl,
vincristine, hydrocortisone, vitamine, nore, vitamink, metoprolol,
pravastatin, mycophenolic, idarubicin, isoproterenol, warfarin,
tacrine, memantine, epinephrine, copper, lithium, dicloxacillin,
ritonavir, nitroprusside, amoxicillin, betamethosone, prednisone,
prednisolone, troleandomycin, lovastatin, tacrolimus, galantamine,
budenoside, cyclosporine, mifepristone, macrolides, erythromycin,
zinc, levonorgestrol, beclome, sirolimus, nitrous oxide, magnesium,
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aldosterone, triamcin, calcitriol

Coronary artery

digoxin, warfarin, pravastatin, metoprolol, nitrous oxide, codeine,

disease

methadone, lovastatin, morphine, nicotine, nitroprusside, estrone,
epinephrine, levonorgestrol, tamoxifen, ritonavir, erythromycin,
galantamine, tacrine, acetaminophen, aldosterone, isoproterenol,
budenoside, vitamine, ethinyl, triamcin, amoxicillin, nore,
hydrocortisone, testosterone, betamethosone, vitamink, macrolides,
lithium, sirolimus, dicloxacillin, mifepristone, curcumin,
tacrolimus, prednisone, prednisolone, copper, beclome, zinc,
magnesium, cyclosporine, mycophenolic, troleandomycin,
calcitriol, vincristine, memantine, idarubicin, cisplatin

Myocardial

metoprolol, isoproterenol, epinephrine, pravastatin, vitamine,

infarction

digoxin, aldosterone, warfarin, lithium, galantamine, vitamink,
nitroprusside, lovastatin, triamcin, nicotine, magnesium,
hydrocortisone, zinc, memantine, testosterone, acetaminophen,
tacrine, sirolimus, copper, calcitriol, nitrous oxide, tamoxifen,
mifepristone, macrolides, morphine, cyclosporine, estrone,
tacrolimus, troleandomycin, codeine, budenoside, betamethosone,
prednisolone, methadone, beclome, curcumin, levonorgestrol,
prednisone, idarubicin, ethinyl, erythromycin, cisplatin,
mycophenolic, vincristine, dicloxacillin, nore, ritonavir, amoxicillin
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Pain

codeine, nitrous oxide, methadone, metoprolol, warfarin, morphine,
digoxin, prednisone, beclome, prednisolone, acetaminophen,
nicotine, mycophenolic, pravastatin, betamethosone, budenoside,
memantine, triamcin, hydrocortisone, nore, aldosterone,
dicloxacillin, levonorgestrol, amoxicillin, lovastatin, epinephrine,
nitroprusside, ritonavir, galantamine, ethinyl, estrone, lithium,
idarubicin, tacrolimus, testosterone, cyclosporine, tamoxifen,
vincristine, vitamink, vitamine, isoproterenol, erythromycin,
troleandomycin, macrolides, mifepristone, magnesium, zinc,
sirolimus, tacrine, cisplatin, copper, calcitriol, curcumin

Leukemia

erythromycin, vitamink, idarubicin, amoxicillin, zinc, ritonavir,
cisplatin, lithium, morphine, macrolides, dicloxacillin, copper,
triamcin, prednisolone, tacrolimus, vincristine, prednisone,
cyclosporine, betamethosone, magnesium, mifepristone, codeine,
acetaminophen, methadone, nitrous oxide, lovastatin, warfarin,
tamoxifen, digoxin, calcitriol, sirolimus, mycophenolic, vitamine,
levonorgestrol, nicotine, metoprolol, beclome, budenoside,
testosterone, hydrocortisone, pravastatin, troleandomycin,
epinephrine, memantine, curcumin, nore, nitroprusside, ethinyl,
estrone, aldosterone, isoproterenol, galantamine, tacrine

Pulmonary

warfarin, acetaminophen, curcumin, vitamine, beclome, vitamink,
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embolism

mycophenolic, prednisolone, budenoside, cisplatin, prednisone,
lovastatin, digoxin, triamcin, pravastatin, ethinyl, levonorgestrol,
amoxicillin, metoprolol, tacrolimus, lithium, betamethosone,
codeine, idarubicin, cyclosporine, vincristine, nore, erythromycin,
nitrous oxide, tamoxifen, macrolides, memantine, sirolimus,
troleandomycin, ritonavir, methadone, magnesium, tacrine,
hydrocortisone, nicotine, aldosterone, copper, nitroprusside,
isoproterenol, estrone, testosterone, dicloxacillin, morphine,
galantamine, mifepristone, calcitriol, epinephrine, zinc

Warfarin

warfarin, pravastatin, prednisone, vincristine, lovastatin,
amoxicillin, methadone, erythromycin, idarubicin, dicloxacillin,
prednisolone, ritonavir, metoprolol, vitamink, digoxin, nitrous
oxide, codeine, mycophenolic, macrolides, sirolimus, tacrolimus,
triamcin, vitamine, acetaminophen, morphine, tamoxifen,
budenoside, betamethosone, cisplatin, cyclosporine, nicotine,
beclome, galantamine, nitroprusside, calcitriol, hydrocortisone,
estrone, aldosterone, tacrine, epinephrine, testosterone, magnesium,
isoproterenol, troleandomycin, lithium, memantine, zinc,
levonorgestrol, curcumin, copper, ethinyl estradiol

Osteosarcoma

vincristine, idarubicin, cisplatin, prednisone, mycophenolic,
curcumin, tacrolimus, cyclosporine, macrolides, sirolimus,

79

tamoxifen, erythromycin, amoxicillin, vitamink, lovastatin,
vitamine, dicloxacillin

Neutropenia

vincristine, idarubicin, cisplatin, prednisone, mycophenolic, nore,
morphine, ethinyl, levonorgestrol, nitrous oxide, dicloxacillin,
estrone, memantine, digoxin, aldosterone, galantamine, tacrolimus,
cyclosporine, amoxicillin, epinephrine, ritonavir, nitroprusside,
budenoside, nicotine, prednisolone, codeine, testosterone, tacrine,
erythromycin, hydrocortisone, methadone, acetaminophen,
tamoxifen, macrolides, beclome, magnesium, betamethosone,
copper, lithium, mifepristone, zinc, pravastatin, lovastatin,
isoproterenol, vitamin E

Schizophrenia

curcumin, nitroprusside, memantine, tamoxifen, isoproterenol,
testosterone, codeine, epinephrine, copper, mifepristone, zinc,
morphine, vitamine, nicotine, tacrine, nitrous oxide, magnesium,
estrone, galantamine, lithium, cisplatin, ethinyl, acetaminophen,
calcitriol, methadone, sirolimus, hydrocortisone, cyclosporine,
troleandomycin, vitamink, nore, macrolides, betamethosone,
lovastatin, tacrolimus, idarubicin, pravastatin, aldosterone, triamcin,
metoprolol, vincristine, ritonavir, digoxin, budenoside, warfarin,
mycophenolic, erythromycin, beclome, prednisolone,
levonorgestrol, dicloxacillin, prednisone, amoxicillin
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B. Associated drugs/Chemicals for 20 selected queries for Global LSA model

Alzheimer disease

Curcumin, tacrine, memantine, metoprolol, vitamine

Neurodegenerative

Tamoxifen, cisplatin, testosterone, curcumin, memantine

disease

Dementia

Memantine, galantamine, nicotine, nitrous oxide, tacrine

Drug Toxicity

Vincristine, warfarin, digoxin, idarubicin, prednisone

Transplantation

Prednisone, mycophenolic acid, prednisolone, triamcin, tacrolimus

Depression

Memantine, galantamine, nicotine, nitrous oxide, tacrine

Venous thrombosis Warfarin, metoprolol, triamcinolone, prednisone, vincristine
Thrombosis

Curcumin, lovastatin, cisplatin, morphine, nicotine

embolism
Breast neoplasm

Aldosterone, pravastatin, lovastatin, tacrine, nitroprusside

Hypertension

mycophenolic, oxide, prednisone, cyclosporine, lithium

Nausea

codeine, morphine, acetaminophen, methadone, digoxin

Coronary artery

digoxin, warfarin, pravastatin, metoprolol, oxide

disease
Myocardial

prednisone, metoprolol, digoxin, mycophenolic, vincristine

infarction
Pain

codeine, oxide, methadone, metoprolol, warfarin

Leukemia

erythromycin, vitamink, idarubicin, amoxicillin, zinc
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Pulmonary

warfarin, acetaminophen, curcumin, vitamine, become

embolism
Warfarin

nitrous oxide, aldosterone, tacrine, galantamine, morphine

Osteosarcoma

vincristine, idarubicin, cisplatin, prednisone, mycophenolic

Neutropenia

vincristine, idarubicin, cisplatin, prednisone, mycophenolic

Schizophrenia

curcumin, nitroprusside, memantine, tamoxifen, isoproterenol
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C. Associated drugs/Chemicals for 20 selected queries for Local LSA model without
sampled information

Alzheimer disease

Tacrine, Galantamine, Digoxin, MycophenolicAcid, Pravastatin,
CopperSulfate, Tacrolimus, Lithium, VitaminE, Cyclosporine,
Lovastatin, Sirolimus, Nicotine, Metoprolol, Zinc, Magnesium,
Curcumin, Macrolides, Nitroprusside, Aldosterone, Isoproterenol,
Acetaminophen, Epinephrine, VitaminK, Prednisone, Memantine,
Prednisolone, Beclomethasone, Budesonide, Hydrocortisone,
Triamcinolone, Erythromycin, Betamethasone, Warfarin, Cisplatin,
Amoxicillin, Calcitriol, Troleandomycin, Testosterone, Tamoxifen,
Ritonavir, Estrone, EthinylEstradiol, Morphine, Idarubicin,
Mifepristone, NitrousOxide, Vincristine, Norethindrone

Neurodegenerative

Curcumin, CopperSulfate, Tacrolimus, Cyclosporine, Lovastatin,

disease

MycophenolicAcid, Sirolimus, Tamoxifen, Memantine, Tacrine,
Macrolides, Calcitriol, Lithium, Ritonavir, Pravastatin, Cisplatin,
Zinc, Triamcinolone, Magnesium, Galantamine, Acetaminophen,
Estrone, Nitroprusside, VitaminE, Digoxin, Prednisolone,
EthinylEstradiol, Mifepristone, Norethindrone, VitaminK,
Prednisone, Erythromycin, Betamethasone, Hydrocortisone,
Troleandomycin, Aldosterone, Nicotine, Testosterone,
Levonorgestrel, Metoprolol, Isoproterenol, Vincristine,
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Epinephrine, Idarubicin, Warfarin, Budesonide, Amoxicillin,
Morphine, Methadone, NitrousOxide, Codeine, Beclomethasone

Dementia

Tacrine, Memantine, Lithium, Digoxin, MycophenolicAcid,
Galantamine, Tacrolimus, Methadone, Metoprolol, Acetaminophen,
Cyclosporine, Triamcinolone, Tamoxifen, Ritonavir, Prednisone,
Curcumin, Sirolimus, Warfarin, Prednisolone, NitrousOxide,
Calcitriol, Morphine, Codeine, Magnesium, Pravastatin,
Macrolides, Isoproterenol, Lovastatin, Betamethasone, Aldosterone,
Nitroprusside, Zinc, VitaminK

Drug

Digoxin, Troleandomycin, Codeine, Idarubicin, Metoprolol,
Morphine, Prednisone, Acetaminophen, MycophenolicAcid,
Methadone, Warfarin, Ritonavir, Cyclosporine, Prednisolone,
Amoxicillin, Erythromycin, Lithium, Pravastatin, Cisplatin,
Tacrine, Vincristine, Tacrolimus, Dicloxacillin, Nicotine,
Curcumin, Macrolides, NitrousOxide, Sirolimus, Lovastatin,
Beclomethasone

Transplantation

Ritonavir, Tamoxifen, Memantine, Tacrine, Tacrolimus,
MycophenolicAcid, Cyclosporine, Lovastatin, Prednisone,
Warfarin, Triamcinolone, Sirolimus, Calcitriol, Betamethasone,
Acetaminophen, Cisplatin, Pravastatin, Digoxin, Methadone,
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Galantamine, Mifepristone, Prednisolone, NitrousOxide, Codeine,
Hydrocortisone, Norethindrone, Vincristine, Metoprolol,
Aldosterone, Macrolides, EthinylEstradiol, Isoproterenol, Estrone,
Levonorgestrel, Lithium, Nitroprusside, Idarubicin

Depression

Tacrine, Memantine, Lithium, Digoxin, MycophenolicAcid,
Galantamine, Tacrolimus, Methadone, Metoprolol, Acetaminophen,
Cyclosporine, Triamcinolone, Tamoxifen, Ritonavir, Prednisone,
Curcumin, Sirolimus, Warfarin, Prednisolone, NitrousOxide,
Calcitriol, Morphine, Codeine, Magnesium, Pravastatin,
Macrolides, Isoproterenol, Lovastatin, Betamethasone, Aldosterone,
Nitroprusside, Zinc, VitaminK

Venous thrombosis Warfarin, VitaminK, Levonorgestrel, Norethindrone, Lovastatin,
Pravastatin, EthinylEstradiol, Tamoxifen, Calcitriol, Prednisolone,
Prednisone, Estrone, Cisplatin, Sirolimus, Triamcinolone,
Mifepristone, Testosterone, Troleandomycin, Cyclosporine,
VitaminE, Vincristine, Macrolides, Tacrolimus,
MycophenolicAcid, Hydrocortisone, Ritonavir, Idarubicin,
Betamethasone, Dicloxacillin, Magnesium, Digoxin, Zinc,
Aldosterone, Erythromycin, CopperSulfate, Nitroprusside,
Acetaminophen, Beclomethasone, Metoprolol, Curcumin,
Epinephrine, Isoproterenol, Budesonide, Lithium, Tacrine,
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Amoxicillin, NitrousOxide, Galantamine, Nicotine, Memantine

Thrombosis

Warfarin, Ritonavir, Lovastatin, Pravastatin, Prednisone,

embolism

Vincristine, Dicloxacillin, Levonorgestrel, Idarubicin, Prednisolone,
Cyclosporine, Calcitriol, Norethindrone, Tamoxifen, Cisplatin,
Mifepristone, EthinylEstradiol, Troleandomycin,
MycophenolicAcid, Sirolimus, Erythromycin, Tacrolimus,
Testosterone, VitaminK, Amoxicillin, Estrone, Macrolides,
Triamcinolone, Digoxin, Betamethasone, Budesonide, Aldosterone,
Hydrocortisone, Nitroprusside, Beclomethasone, Curcumin,
Metoprolol, Isoproterenol

Breast neoplasm

Tamoxifen, Norethindrone, Estrone, EthinylEstradiol,
Levonorgestrel, Testosterone, Cisplatin, Mifepristone, Vincristine,
Idarubicin, Prednisone, Hydrocortisone, Calcitriol, Prednisolone,
Ritonavir, Triamcinolone, Cyclosporine, Sirolimus, Galantamine,
Lithium, MycophenolicAcid, Tacrolimus, Betamethasone,
Memantine, Magnesium, Epinephrine, Zinc, Aldosterone, Nicotine,
VitaminE, Curcumin, Macrolides, Isoproterenol, Digoxin,
Lovastatin, Warfarin, Morphine, CopperSulfate, Nitroprusside,
Tacrine, Budesonide, Pravastatin, VitaminK, Troleandomycin,
Beclomethasone, Acetaminophen, Methadone, Codeine,
Erythromycin, Amoxicillin, Metoprolol, Dicloxacillin
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Hypertension

Budesonide, Mifepristone, Prednisolone, Testosterone,
Levonorgestrel, Lovastatin, Pravastatin, Betamethasone,
Prednisone, Beclomethasone, Troleandomycin, Hydrocortisone,
Norethindrone, EthinylEstradiol, Calcitriol, Estrone, Cisplatin,
Cyclosporine, Warfarin, Vincristine, Aldosterone, Sirolimus,
Triamcinolone, Macrolides, Ritonavir, Tacrolimus,
MycophenolicAcid, Nitroprusside, Zinc, Dicloxacillin,
Epinephrine, Isoproterenol, VitaminE, VitaminK, Tamoxifen,
Magnesium, Erythromycin, Idarubicin, Nicotine, CopperSulfate,
Digoxin, Amoxicillin, Acetaminophen, Lithium, Metoprolol,
Curcumin, Morphine, Codeine, NitrousOxide, Galantamine,
Methadone, Tacrine, Memantine

Nausea

Nill

Coronary artery

Pravastatin, Lovastatin, Digoxin, Warfarin, Sirolimus, Aldosterone,

disease

Cyclosporine, Troleandomycin, Nitroprusside, Macrolides,
Prednisolone, Metoprolol, MycophenolicAcid, Tacrolimus,
Magnesium, Ritonavir, VitaminE, Curcumin, Zinc, Calcitriol,
Nicotine, Levonorgestrel, Prednisone, Testosterone, VitaminK,
EthinylEstradiol, Isoproterenol, CopperSulfate, Lithium,
Mifepristone, Epinephrine, Budesonide, Triamcinolone,
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Norethindrone, Estrone, Erythromycin, Hydrocortisone, Cisplatin,
Betamethasone, Beclomethasone, Dicloxacillin, Idarubicin,
Vincristine, Tamoxifen, Acetaminophen, Amoxicillin,
Galantamine, Memantine, Tacrine, NitrousOxide, Morphine,
Methadone, Codeine

Myocardial

Troleandomycin, Budesonide, Prednisolone, Beclomethasone,

infarction

Betamethasone, Mifepristone, Levonorgestrel, Pravastatin,
Lovastatin, Prednisone, Testosterone, Hydrocortisone, Warfarin,
EthinylEstradiol, Cisplatin, Calcitriol, Norethindrone,
Cyclosporine, Macrolides, Sirolimus, Aldosterone, Estrone,
Triamcinolone, Tacrolimus, Nitroprusside, Zinc,
MycophenolicAcid, Vincristine, Magnesium, Erythromycin,
Isoproterenol, Epinephrine, Digoxin, VitaminK, Dicloxacillin,
VitaminE, Nicotine, Ritonavir, Tamoxifen, Amoxicillin,
Acetaminophen, Metoprolol, CopperSulfate, Lithium, Idarubicin,
Curcumin, Morphine, Codeine, NitrousOxide, Galantamine,
Tacrine, Methadone, Memantine

Pain

nill

Leukemia

Vincristine, Prednisone, Idarubicin, Prednisolone, Cisplatin,
Ritonavir, Cyclosporine, Budesonide, Troleandomycin,
Testosterone, Calcitriol, Levonorgestrel, Mifepristone, Macrolides,
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EthinylEstradiol, Estrone, Norethindrone, Lovastatin, Sirolimus,
Tacrolimus, MycophenolicAcid, Pravastatin, Triamcinolone,
Betamethasone, Hydrocortisone, Zinc, Curcumin, Dicloxacillin,
Warfarin, Beclomethasone, Magnesium, Erythromycin, VitaminK,
VitaminE, Aldosterone, Tamoxifen, Nitroprusside, Amoxicillin,
Digoxin, CopperSulfate, Isoproterenol, Lithium, Epinephrine,
Acetaminophen, Nicotine, Metoprolol, Morphine, NitrousOxide,
Codeine, Methadone, Memantine, Galantamine, Tacrine

Pulmonary

Warfarin, VitaminK, Levonorgestrel, Norethindrone,

embolism

EthinylEstradiol, Tamoxifen, Pravastatin, Lovastatin, Prednisolone,
Calcitriol, Prednisone, Cisplatin, Troleandomycin, Estrone,
Mifepristone, Sirolimus, Cyclosporine, Digoxin, Triamcinolone,
VitaminE, Acetaminophen, Hydrocortisone, Testosterone,
Betamethasone, Ritonavir, Zinc, Macrolides, Magnesium,
Metoprolol, Tacrolimus, Vincristine, Nitroprusside, Aldosterone,
MycophenolicAcid, Dicloxacillin, Isoproterenol, CopperSulfate,
Beclomethasone, Epinephrine, Lithium, Erythromycin, Idarubicin,
Curcumin, Budesonide, Tacrine, Amoxicillin, Nicotine,
NitrousOxide, Memantine, Galantamine, Morphine, Codeine,
Methadone

Warfarin

Nicotine, Morphine, Metoprolol, NitrousOxide, Epinephrine,
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Isoproterenol, Beclomethasone, Nitroprusside, Codeine, Digoxin,
Troleandomycin, Lithium, Magnesium, Acetaminophen,
Aldosterone, Budesonide, Zinc, Methadone, CopperSulfate,
Galantamine, Tacrine, Hydrocortisone, VitaminE, Betamethasone,
Testosterone, Memantine, Mifepristone, Erythromycin, VitaminK,
Macrolides, Curcumin, Amoxicillin, Dicloxacillin, Estrone,
EthinylEstradiol, Prednisolone, Cisplatin, Levonorgestrel,
Norethindrone, Triamcinolone, Warfarin, Sirolimus, Cyclosporine,
Pravastatin, Calcitriol

Osteosarcoma

NitrousOxide, Methadone, Ritonavir, Tacrine, Memantine,
Metoprolol, Isoproterenol, Aldosterone, Hydrocortisone, Morphine,
Nitroprusside, Digoxin, Epinephrine, Acetaminophen,
Levonorgestrel, EthinylEstradiol, Warfarin, Lithium,
Norethindrone, Galantamine, Estrone, Mifepristone, Testosterone,
Tamoxifen, Lovastatin, Betamethasone, Prednisone, Vincristine,
Codeine, Budesonide, Triamcinolone, Cyclosporine, Prednisolone,
Calcitriol, Nicotine, Magnesium, Pravastatin, Beclomethasone,
Tacrolimus, Zinc, Idarubicin, Sirolimus, VitaminK,
Troleandomycin, Macrolides, Cisplatin, MycophenolicAcid,
Curcumin, VitaminE, Dicloxacillin, Erythromycin, CopperSulfate

Neutropenia

Dicloxacillin
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Schizophrenia

Tacrine, Nicotine, Lithium, Galantamine, Morphine, Methadone,
NitrousOxide, Acetaminophen, Memantine, Epinephrine,
EthinylEstradiol, Levonorgestrel, Zinc, Magnesium, Codeine,
Norethindrone, Estrone, Metoprolol, Hydrocortisone, Digoxin,
VitaminE, Nitroprusside, VitaminK, Isoproterenol, Mifepristone,
CopperSulfate, Tamoxifen, Testosterone, Aldosterone,
Troleandomycin, Betamethasone, Warfarin, Beclomethasone,
Curcumin, Calcitriol, Budesonide, Cisplatin, Triamcinolone,
Macrolides, Prednisolone, Pravastatin, Cyclosporine, Ritonavir,
Erythromycin, Lovastatin, Sirolimus, Tacrolimus, Prednisone,
Amoxicillin, Dicloxacillin, Vincristine, Idarubicin,
MycophenolicAcid
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D. Cosine values for the associated drugs/chemicals for 20 selected queries for the
proposed LLSA model in the retrieved order
Alzheimer disease

0.0903 0.0683 0.0667 0.0565 0.0565 0.0563 0.0541 0.049 0.0297
0.0291 0.0229 0.0221 0.0186 0.0156 0.0143 0.0135 0.0122 0.011
0.009 0.0084 0.0071

Neurodegenerative

0.1368 0.1326 0.1295 0.1141 0.1135 0.1112 0.1076 0.1027 0.1019

disease

0.0983 0.098 0.0977 0.0953 0.0915 0.0875 0.0863 0.0828 0.0799
0.0681 0.0677 0.0669 0.0657 0.0652 0.0649 0.0633 0.0613 0.0588
0.0588 0.0531 0.0529 0.0496 0.048 0.0473 0.0471 0.047 0.0464
0.046 0.0414 0.0398 0.0278 0.0257 0.0228 0.0141 0.0078 0.0045
0.0041 0.0033 0.0026 0.001

Dementia

0.1853 0.1607 0.1379 0.1355 0.1289 0.1185 0.1185 0.1124 0.1114
0.1102 0.1092 0.103 0.0898 0.0786 0.0782 0.0764 0.0713 0.0684
0.0679 0.0665 0.0651 0.0563 0.0552 0.0542 0.054 0.0538 0.0518
0.0517 0.0503 0.0484 0.0472 0.0419 0.0375 0.0292 0.0287 0.0266
0.025 0.0244 0.0231 0.023 0.0192 0.0176 0.011 0.0088 0.0069

Drug Toxicity

0.1726 0.1684 0.1651 0.1622 0.1587 0.1539 0.1341 0.1306 0.1305
0.1264 0.1208 0.1154 0.1153 0.1149 0.114 0.1104 0.1101 0.1079
0.105 0.1027 0.1008 0.0997 0.0988 0.0981 0.0962 0.0937 0.0906
0.0904 0.0893 0.084 0.0833 0.0797 0.0754 0.0753 0.075 0.0715
92

0.0687 0.0685 0.0644 0.0629 0.0554 0.0533 0.0429 0.0391 0.0386
0.0359 0.0351 0.0321 0.0275 0.0226 0.0223 0.0175

Transplantation

0.3722 0.3688 0.3491 0.3378 0.332 0.3257 0.3199 0.3182 0.3173
0.3128 0.304 0.3034 0.3018 0.2997 0.2976 0.297 0.2962 0.2793
0.265 0.2609 0.2576 0.2551 0.255 0.2512 0.2395 0.2384 0.2379
0.2335 0.2312 0.2291 0.2257 0.2252 0.2252 0.2215 0.2163 0.2148
0.2137 0.2127 0.2121 0.2118 0.2101 0.2028 0.2009 0.1997 0.1986
0.1833 0.1799 0.1608 0.1592 0.1544 0.1501 0.1478 0.1409

Depression

0.1853 0.1607 0.1379 0.1355 0.1289 0.1185 0.1185 0.1124 0.1114
0.1102 0.1092 0.103 0.0898 0.0786 0.0782 0.0764 0.0713 0.0684
0.0679 0.0665 0.0651 0.0563 0.0552 0.0542 0.054 0.0538 0.0518
0.0517 0.0503 0.0484 0.0472 0.0419 0.0375 0.0292 0.0287 0.0266
0.025 0.0244 0.0231 0.023 0.0192 0.0176 0.011 0.0088 0.0069

Venous thrombosis 0.1156 0.1023 0.0766 0.0746 0.0491 0.0479 0.0435 0.0386 0.0357
0.0318 0.0293 0.0289 0.0261 0.025 0.0235 0.0216 0.0149 0.0146
0.0101 0.0089 0.0088 0.0028

Thrombosis

0.3225 0.3224 0.3006 0.2943 0.2918 0.291 0.2879 0.2847 0.2826

embolism

0.2815 0.2774 0.273 0.2723 0.2723 0.2679 0.2673 0.2655 0.2648
0.2571 0.2562 0.256 0.2559 0.2549 0.2544 0.2537 0.2535 0.2522
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0.2517 0.2498 0.2494 0.2488 0.2487 0.2477 0.2469 0.2461 0.2452
0.2451 0.2444 0.2444 0.2439 0.2385 0.2371 0.2349 0.2332 0.232
0.2317 0.2282 0.2255 0.2246 0.2153 0.2145 0.2044 0.1876

Breast neoplasm

0.2294 0.2262 0.2236 0.2138 0.2119 0.2067 0.2007 0.1967 0.1942
0.1923 0.1923 0.1875 0.1866 0.1826 0.1809 0.1809 0.1807 0.1804
0.1781 0.1778 0.1768 0.176 0.1753 0.1723 0.1719 0.1709 0.17
0.168 0.1665 0.1654 0.1635 0.1633 0.1631 0.1613 0.1598 0.1585
0.1575 0.1571 0.1565 0.1557 0.1537 0.1531 0.1506 0.1496 0.1481
0.148 0.1476 0.1454 0.1447 0.1429 0.133 0.1301 0.1108

Hypertension

0.4949 0.4747 0.467 0.4669 0.4639 0.4591 0.4589 0.4546 0.4517
0.4489 0.448 0.446 0.4423 0.442 0.4391 0.4383 0.4366 0.4346
0.432 0.4272 0.4264 0.4237 0.4226 0.4225 0.4187 0.4163 0.4143
0.4122 0.4117 0.4103 0.4083 0.4039 0.4028 0.3999 0.3998 0.3986
0.3983 0.3975 0.3944 0.394 0.3908 0.3823 0.3801 0.3785 0.3721
0.3716 0.3704 0.3646 0.3626 0.3595 0.3395 0.3311 0.3194

Nausea

0.4106 0.3823 0.3481 0.3451 0.3377 0.3354 0.3312 0.3259 0.3255
0.3215 0.3184 0.3172 0.3148 0.3133 0.3129 0.3121 0.3066 0.3058
0.3056 0.3054 0.3046 0.3024 0.3023 0.3023 0.3022 0.3018 0.3011
0.2994 0.2985 0.2974 0.2963 0.2958 0.2946 0.293 0.2923 0.2909
0.2896 0.2892 0.2883 0.2883 0.2869 0.2843 0.2833 0.2808 0.2795
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0.2787 0.2755 0.2744 0.2738 0.2694 0.2647 0.2578 0.2523

Coronary artery

0.1696 0.1555 0.1487 0.1388 0.1386 0.1256 0.1211 0.1208 0.1168

disease

0.1081 0.1026 0.0919 0.0901 0.0886 0.0861 0.0854 0.0843 0.0813
0.0786 0.0783 0.0776 0.0769 0.0766 0.0749 0.0719 0.0713 0.071
0.07 0.0687 0.0684 0.0649 0.064 0.0628 0.0618 0.0601 0.0503
0.0495 0.0488 0.0484 0.0473 0.0472 0.0454 0.0442 0.0439 0.0438
0.0362 0.0359 0.0318 0.022 0.0212 0.0187 0.0143 0.003

Myocardial

0.3417 0.3055 0.2976 0.2949 0.2937 0.2922 0.2903 0.2878 0.2826

infarction

0.2812 0.2772 0.2754 0.2751 0.2691 0.267 0.2618 0.2548 0.2541
0.2529 0.2514 0.2511 0.2502 0.2482 0.2365 0.2333 0.2309 0.2271
0.2264 0.2241 0.2229 0.2211 0.2204 0.2195 0.2176 0.2166 0.2159
0.2155 0.2137 0.2127 0.209 0.2034 0.2016 0.1995 0.1962 0.1933
0.193 0.1919 0.1916 0.1869 0.1786 0.1734 0.1706 0.1695

Pain

0.3418 0.3118 0.3067 0.2973 0.2914 0.2891 0.2873 0.2622 0.2589
0.2569 0.256 0.2555 0.2533 0.2489 0.2424 0.24 0.234 0.233 0.2311
0.2303 0.2241 0.2238 0.2234 0.2209 0.2196 0.219 0.2154 0.2154
0.2127 0.2103 0.2091 0.2077 0.2048 0.1998 0.1975 0.1951 0.1942
0.1882 0.1875 0.1835 0.1834 0.1803 0.1729 0.1615 0.1608 0.1598
0.153 0.151 0.1484 0.1479 0.1394 0.1293 0.0992

Leukemia

0.1227 0.1134 0.1133 0.1125 0.1054 0.1016 0.0939 0.0919 0.0918
0.0896 0.088 0.0853 0.0841 0.0831 0.083 0.0825 0.0819 0.0795
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0.0775 0.0764 0.0735 0.0724 0.0719 0.0718 0.0704 0.0699 0.0689
0.0689 0.0674 0.0661 0.0657 0.0653 0.0645 0.0586 0.0583 0.0573
0.0565 0.0546 0.0545 0.0542 0.0529 0.0506 0.0504 0.0472 0.0431
0.04 0.0399 0.0385 0.0373 0.0339 0.0164 0.0132 0.011

Pulmonary

0.1821 0.1543 0.1493 0.1486 0.1412 0.1348 0.1331 0.1303 0.1284

embolism

0.123 0.1226 0.12 0.1193 0.1161 0.116 0.1158 0.1141 0.1098
0.1096 0.1096 0.1072 0.1069 0.1062 0.1051 0.1022 0.0988 0.0967
0.0959 0.095 0.0944 0.0932 0.0918 0.0891 0.0865 0.0843 0.0836
0.0812 0.081 0.0809 0.0784 0.0757 0.0752 0.0717 0.0717 0.0707
0.0706 0.0701 0.0689 0.061 0.0597 0.0596 0.0553 0.0517

Warfarin

0.0812 0.0633 0.0606 0.0538 0.0495 0.0456 0.0421 0.0412 0.0399
0.0383 0.0372 0.0359 0.0345 0.0319 0.0282 0.0252 0.0229 0.0227
0.0221 0.0203 0.0196 0.0193 0.0164 0.0161 0.0152 0.0146 0.0144
0.0141 0.0124 0.0114 0.011 0.0106 0.0098 0.007 0.0048 0.0047
0.0029 0.0028 0.001

Osteosarcoma

0.1078 0.103 0.0944 0.0478 0.0326 0.0325 0.0286 0.0273 0.025
0.0225 0.0208 0.0159 0.0077 0.0024 0.0024 7.0E-4 3.0E-4

Neutropenia

0.0879 0.0819 0.0796 0.0682 0.0679 0.0657 0.0651 0.0616 0.0579
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0.053 0.0529 0.0517 0.0488 0.0484 0.0469 0.0466 0.0458 0.0444
0.0442 0.0412 0.0406 0.0405 0.0402 0.0362 0.0354 0.0342 0.0327
0.0325 0.0312 0.03 0.0289 0.0253 0.0219 0.0214 0.0208 0.0204
0.0202 0.0185 0.0142 0.0093 0.0078 0.0071 0.0058 0.0011 0.001

Schizophrenia

0.2344 0.2157 0.2119 0.2019 0.1959 0.1939 0.1934 0.1914 0.1904
0.1904 0.1888 0.1883 0.1869 0.1853 0.1853 0.185 0.1828 0.1825
0.1788 0.1699 0.1643 0.1565 0.1564 0.1551 0.1518 0.1507 0.1506
0.1452 0.1444 0.1434 0.1433 0.1421 0.1292 0.1292 0.1256 0.1237
0.117 0.1166 0.1102 0.1087 0.1056 0.1041 0.1036 0.1033 0.1025
0.1008 0.095 0.0904 0.0853 0.0797 0.0678 0.0671 0.0519
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